Supportive and Palliative Care in Cancer Therapies—Path from Tumor-Driven Therapies to Patient-Driven Ones — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Supportive and Palliative Care in Cancer Therapies—Path from Tumor-Driven Therapies to Patient-Driven Ones
Wits Donald Gordon Medical Center, Department of Radiation Oncology, Johannesburg, South Africa
,
Department of Radiation Sciences, University of the Witwatersrand, Gauteng, South Africa
,
Biotechnics Department, Hungarian University of Agriculture and Life Sciences, Godollo, Hungary
,
Department of Radiation Oncology, Jeonbuk National University Medical School, Jeonbuk, Republic of Korea
,
Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical, Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea
,
Semmelweis University, Innovation Center, Budapest, Hungary
,
Division of Oncology, 1st Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary
,
Department of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis University, Budapest, Hungary
1 Wits Donald Gordon Medical Center, Department of Radiation Oncology, Johannesburg, South Africa
2 Department of Radiation Sciences, University of the Witwatersrand, Gauteng, South Africa
3 Biotechnics Department, Hungarian University of Agriculture and Life Sciences, Godollo, Hungary
4 Department of Radiation Oncology, Jeonbuk National University Medical School, Jeonbuk, Republic of Korea
5 Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical, Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea
6 Semmelweis University, Innovation Center, Budapest, Hungary
7 Division of Oncology, 1st Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary
8 Department of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis University, Budapest, Hungary
Cancer patients frequently report a set of symptoms including fatigue, pain, and physiological and social distress. Families and other personal lay relations give proposals to take supportive drugs and supplemental nutrients, without professional knowledge about their actions. Internet search engines and social networks serve up most of the treatment proposals, opening wide possibilities for quackeries and predatory money-making practices. Medical professionals have a responsibility to clear this field and concentrate on patients’ well-being and personal needs. According to our approach, the integration of supportive and palliative care with conventional therapies needs a change of paradigm from tumour-driven to patient-driven treatment actions. Supportive/palliative care includes a broad spectrum of applied methods, including medications, nourishments, electrical effects, and psycho and social supports. Our goal is to discuss the possibilities for combining conventional oncotherapies with additional supportive/palliative care and to give suggestions on a professional basis.
Improving Supportive and Palliative Care for Adults with Cancer—The Manual. National Institute for Clinical Excellence. https://www.nice.org.uk/guidance/csg4
Zafar, S.Y., Currow, D.C., Cherny, N., et al. (2012) Consensus-Based Standards for Best Supportive Care in Clinical Trials in Advanced Cancer. The Lancet Oncology, 13, e77-e82. https://doi.org/10.1016/S1470-2045(11)70215-7
Cancer Supportive Care Drugs Market Size US$ 21.8 Bn by 2026. https://www.globenewswire.com/news-release/2019/07/02/1877384/0/en/Cancer-Supportive-Care-Drugs-Market-Size-US-21-8-Bn-by-2026.html
Cancer Treatment and Survivorship, Facts and Figures 2019-2021. American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-treatment-and-survivorship-facts-and-figures/cancer-treatment-and-survivorship-facts-and-figures-2019-2021.pdf
Rohdenburg (1918) Fluctuations in the Growth Energy of Tumors in Man, with Esspecial Reference to Spontaneous Recession. Journal of Cancer Research, 3, 193-225.
Fauvet, J. (1964) Spontaneous Cancer Cures and Regressions. Revue du Praticien, 14, 2177-2180.
Boyd, W. (1966) The Spontaneous Regression of Cancer. Charles Thomas, Springfield.
O’Regan, B. and Hirschberg, C. (1993) Spontaneous Remission: An Annotated Bibliography. Institute of Noetic Sciences, Sausalito.
Hobohm, U. (2005) Fever Therapy Revisited. British Journal of Cancer, 92, 421-425. https://doi.org/10.1038/sj.bjc.6602386
Cole, W.H. (1976) Spontaneous Regression of Cancer and the Importance of Finding Its Cause. National Cancer Institute Monographs No. 44, 5-9.
Hobohm, U., Grange, J. and Stanford, J. (2008) Pathogen Associated Molecular Pattern in Cancer Immunotherapy. Critical Reviews Immunology, 28, 95-107. https://doi.org/10.1615/CritRevImmunol.v28.i2.10
Zahl, P.H., Mæhlen, J. and Welch, H.G. (2008) The Natural History of Invasive Breast Cancers Detected by Screening Mammography. Archives of Internal Medicine, 168, 2311-2316. https://doi.org/10.1001/archinte.168.21.2311
Cole, W.H. and Everson, T.C. (1966) Spontaneous Regression of Cancer. WB Saunders, Philadelphia.
Everson, T. and Cole, W. (1968) Spontaneous Regression of Cancer. JB Saunder & Co., Philadelphia.
Challis, G.B. and Stam, H.J. (1990) The Spontaneous Regression of Cancer. A Review of Cases from 1900-1987. Acta Oncologica, 29, 545-550. https://doi.org/10.3109/02841869009090048
Hobohm, U. (2001) Fever and Cancer in Perspective. Cancer Immunology, Immunotherapy, 50, 391-396. https://doi.org/10.1007/s002620100216
Coffey, D.S., Getzenberg, R.H. and DeWeese, T.L. (2006) Hyperthermic Biology and Cancer Therapies: A Hypothesis for the “Lance Armstrong Effect”. JAMA, 296, 445-448. https://doi.org/10.1001/jama.296.4.445
Kocasli, S. and Demircan, Z. (2017) Herbal Product Use by the Cancer Patients in Both Pre and Post Surgery Periods and during Chemotherapy. African Journal of Traditional, Complementary, and Alternative Medicines, 14, 325-333. https://doi.org/10.21010/ajtcam.v14i2.34
McCune, J.S., Hatfield, A.J., Blackburn, A.A.R., et al. (2004) Potential of Chemotherapy-Herb Interactions in Adult Cancer Patients. Supportive Care in Cancer, 12, 454-462. https://doi.org/10.1007/s00520-004-0598-1
Weiger, W.A., Smith, M., Boon, H., Richardson, M.A., Kaptchuk, T.J. and Eisenberg, D.M. (2002) Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer. Annals of Internal Medicine, 137, 889-903. https://doi.org/10.7326/0003-4819-137-11-200212030-00010
Sanson, Fisher, R., Girgis, A., Boyes, A., et al. (2000) The Unmet Supportive Care Needs of Patients with Cancer. Cancer, 88, 226-237. https://doi.org/10.1002/(SICI)1097-0142(20000101)88:1 3.0.CO;2-P
O’Connor, M., Drummond, F., et al. (2019) The Unmet Needs of Cancer Survivors in Ireland: A Scoping Review. Irish Cancer Society. https://www.cancer.ie
Boullata, J.I. and Hudson, L.M. (2012) Drug-Nutrient Interactions: A Broad View with Implications for Practice. Journal of the Academy of Nutrition and Dietetics, 112, 506-517. https://doi.org/10.1016/j.jada.2011.09.002
Fradgley, E.A., Bultz, B.D., Kelly, B.J., et al. (2019) Progress toward Integratingdistress as the Sixth Vital Sign: A Global Snapshot of Triumphs and Tribulations in Precision Supportive Care. Journal of Psychosocial Oncology Research and Practice, 1, e2. https://doi.org/10.1097/OR9.0000000000000002
Fielding, R., Lam, W.W., Shun, S.C., Okuyama, T., Lai, Y.H., Wada, M., Akechi, T. and Li, W.W. (2013) For Asia-Pacific Psycho-Oncology Network (APPON) Attributing Variance in Supportive Care Needs during Cancer: Culture-Service, and Individual Differences before Clinical Factors. PLOS ONE, 8, e65099. https://doi.org/10.1371/journal.pone.0065099
Need for Supportive Care in Oncology Will Increase during the Next Decade, 13 February 2018. https://www.globaldata.com/need-supportive-care-oncology-will-increase-next-decade
Bonevski, B., et al. (2000) Evaluation of an Instrument to Assess the Needs of Patients with Cancer. Supportive Care Review Group. Cancer, 88, 217-225. https://doi.org/10.1002/(SICI)1097-0142(20000101)88:1 3.0.CO;2-Y
Chan, A., Lees, J. and Keefe, D. (2014) The Changing Paradigm for Supportive Care in Cancer Patients. Supportive Care in Cancer, 22, 1441-1445. https://doi.org/10.1007/s00520-014-2229-9
Seow, H. and Bainbridge, B. (2017) A Review of the Essential Components of Quality Palliative Care in the Home. Journal of Palliative Medicine, 20, S37-S44. https://doi.org/10.1089/jpm.2017.0392
Johnson, S.B., Butow, P.N., Bell, M.L., et al. (2018) A Randomized Controlled Trial of an Advance Care Planning Intervention for Patients with Incurable Cancer. British Journal of Cancer, 119, 1182-1190. https://doi.org/10.1038/s41416-018-0303-7
Glare, P.A. (2013) Early Implementation of Palliative Care Can Improve Patient Outcomes. Journal of National Comprehensive Cancer Network, 11, S3-S9. https://doi.org/10.6004/jnccn.2013.0212
Thomas, K. (2003) Caring for the Dying at Home. Companions on a Journey. Radcliffe Medical Press, Oxford.
Kaasa, S., Loge, J.H., Aapro, M., et al. (2018) Integration of Oncology and Palliative Care: A Lancet Oncology Commission. The Lancet Oncology, 19, E588-E653. https://doi.org/10.1016/S1470-2045(18)30415-7
Smyth, J.F. (2008) Disclosing Gaps between Supportive and Palliative Care—The Past 20 Years. Supportive Care in Cancer, 16, 109-111. https://doi.org/10.1007/s00520-007-0354-4
West, B.J. (2006) Where Medicine Went Wrong: Rediscovering the Path to Complexity. World Scientific, London. https://doi.org/10.1142/6175
Senn, H.J., Glaus, A. and Schmid, L. (1988) Supportive Care in Cancer Patients. Springer-Verlag, Berlin. https://doi.org/10.1007/978-3-642-82932-1
Palliative Care Definition by WHO. https://www.who.int/cancer/palliative/definition/en
Nwosu, A.C., Sturgeon, B., McGlinchey, T., et al. (2019) Rotobic Technology for Palliative and Supportive Care: Strengths, Weaknesses, Opportunities and Threats. Paliative Medicine, 33, 1106-1113. https://doi.org/10.1177/0269216319857628
Keefe, D., Garni, A., Villalon, A., et al. (2016) Challenges in Supportive Cancer Care: Perspectives from the Asia Pacific and Middle East. Supportive Care in Cancer, 24, 4479-4481. https://doi.org/10.1007/s00520-016-3381-1
Keefe, D.M. and Bateman, E.H. (2012) Tumor Control versus Adverse Events with Targeted Anticancer Therapies. Nature Reviews Clinical Oncology, 9, 98-109. https://doi.org/10.1038/nrclinonc.2011.192
Chan, A., Chiang, Y.Y., Low, X.H., et al. (2013) Affordability of Cancer Treatment for Aging Cancer Patients in Singapore: An Analysis of Health, Lifestyle, and Financial Burden. Supportive Care in Cancer, 21, 3509-3517. https://doi.org/10.1007/s00520-013-1930-4
Brower, V. (2016) Hyperprogressive Disease with Anti-PD-1 and Anti-PD-L1. Clinical Cancer Research, 17, e527. https://doi.org/10.1016/S1470-2045(16)30590-3
Gelao, L., Criscitiello, C., Esposito, A., et al. (2014) Immune Checkpoint Blockade in Cancer Treatment: A Double-Edged Sword Cross-Targeting the Host as an “Innocent Bystander”. Toxins, 6, 914-933. https://doi.org/10.3390/toxins6030914
Sikora, K., Advani, S., Koroltchouk, V., et al. (1999) Essential Drugs for Cancer Therapy: A World Health Organization Consultation. Annals of Oncology, 10, 385-390. https://doi.org/10.1023/A:1008367822016
Markiewski, M.M. and Lambris, J.D. (2009) Is Complement Good or Bad for Cancer Patients? A New Perspective on an Old Dilemma. Trends in Immunology, 30, 286-292. https://doi.org/10.1016/j.it.2009.04.002
MacDonald, N. (2007) Cancer Cachexia and Targeting Chronic Inflammation: A Unified Approach to Cancer Treatment and Palliative/Supportive Care. The Journal of Supportive Oncology, 5, 157-162.
Barni, S., Lissoni, P., Cazzaniga, M., et al. (1995) A Randomized Study of Low-Dose Subcutaneous Interleukin-2 plus Melatonin versus Supportive Care Alone in Metastatic Colorectal Cancer Patients Progressing under 5-Fluorouracil and Folates. Oncology, 52, 243-245. https://doi.org/10.1159/000227465
Kleckner, A.S., Kleckner, I.R., Kamen, C.S., et al. (2019) Opportunities for Cannabis in Supportive Care in Cancer. Therapeutic Advances in Medical Oncology, 11, 1-29. https://doi.org/10.1177/1758835919866362
Welsh Assembly Government (2001) Improving Health in Wales: A Plan for the NHS with Its Partners. Welsh Assembly Government, Cardiff.
Irwin, K.E., Greer, J.A., Khatib, J., et al. (2013) Early Palliative Care and Metastatic Non-Small Cell Lung Cancer: Potential Mechanisms of Prolonged Survival. Chronic Respiratory Disease, 10, 35-47. https://doi.org/10.1177/1479972312471549
Leutz, W.N. (1999) Five Laws for Integrating Medical and Social Services: Lessons from the United States and the United Kingdom. The Milbank Quarterly, 77, 77-110. https://doi.org/10.1111/1468-0009.00125
Haun, M.W., Estel, S., Rücker, G., et al. (2017) Early Palliative Care for Adults with Advanced Cancer. Cochrane Database of Systematic Reviews, 6, CD011129. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011129.pub2/abstract
Hui, D., Elsayem, A., DelaCruz, M., et al. (2010) Availability and Integration of Palliative Care at US Cancer Centers. JAMA, 303, 1054-1061. https://doi.org/10.1001/jama.2010.258
Gelfman, L.P. and Morrison, R.S. (2008) Research Funding for Palliative Medicine. Journal of Palliative Medicine, 11, 36-43. https://doi.org/10.1089/jpm.2006.0231
Abrahm, J.L. (2012) Integrating Palliative Care into Comprehensive Cancer Care. Journal of the National Comprehensive Cancer Network, 10, 1192-1198. https://doi.org/10.6004/jnccn.2012.0126
Goldsmith, B., Dietrich, J., Du, Q., et al. (2008) Variability in Access to Hospital Palliative Care in the United States. Journal of Palliative Medicine, 11, 1094-1102. https://doi.org/10.1089/jpm.2008.0053
Morrison, R.S., Augustin, R., Souvanna, P., et al. (2011) America’s Care of Serious Illness: A State-by-State Report Card on Access to Palliative Care in Our Nation’s Hospitals. Journal of Palliative Medicine, 14, 1094-1096. https://doi.org/10.1089/jpm.2011.9634
Howie, L. and Peppercorn, J. (2013) Early Palliative Care in Cancer Treatment: Rationale, Evidence and Clinical Implications. Therapeutic Advances in Medical Oncology, 5, 318-323. https://doi.org/10.1177/1758834013500375
Kamal, A.H., Gradison, M., Maguire, J.M., et al. (2014) Quality Measures for Palliative Care in Patients with Cancer: A Systematic Review. Journal of Oncology Practice, 10, 281-287. https://doi.org/10.1200/JOP.2013.001212
Portman, D. and Thirlwell, S. (2015) Perspectives, Progress and Opportunities for Palliative Care in Oncology. Cancer Control, 22, 382-384. https://doi.org/10.1177/107327481502200402
Ramchandran, K., Tribett, E., Dietrich, B., et al. (2015) Integrating Palliative Care into Oncology: A Way Forward. Cancer Control, 22, 386-395. https://doi.org/10.1177/107327481502200404
Smith, T.J., Temin, S., Alesi, E.R., et al. (2012) American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care into Standard Oncology Care. Journal of Clinical Oncology, 30, 880-887. https://doi.org/10.1200/JCO.2011.38.5161
American Society of Clinical Oncology (1998) Cancer Care during the Last Phase of Life. Journal of Clinical Oncology, 16, 1986-1996. https://doi.org/10.1200/JCO.1998.16.5.1986
Cherny, N., Catane, R., Schrijvers, D., et al. (2010) European Society for Medical Oncology (ESMO) Program for the Integration of Oncology and Palliative Care: A 5-Year Review of the Designated Centers’ Incentive Program. Annals of Oncology, 21, 362-369. https://doi.org/10.1093/annonc/mdp318
Kamal, A.H., Harrison, K.L., Bakitas, M., et al. (2015) Improving the Quality of Palliative Care through National and Regional Collaboration Efforts. Cancer Control, 22, 396-402. https://doi.org/10.1177/107327481502200405
Jacobsen, P.B. and Lee, M. (2015) Integrating Psychosocial Care into Routine Cancer Care. Cancer Control, 22, 442-449. https://doi.org/10.1177/107327481502200410
Baitas, M.A., Elk, R., Astin, M., et al. (2015) Systematic Review of Palliative Care in the Rural Setting. Cancer Control, 22, 450-464. https://doi.org/10.1177/107327481502200411
Hui, D. (2015) Prognostication of Survival in Patients with Advanced Cancer: Predicting the Unpredictable? Cancer Control, 22, 489-497. https://doi.org/10.1177/107327481502200415
Tassinari, D., Montanari, L., Maltoni, M., et al. (2008) The Palliative Prognostic Score and Survival in Patients with Advanced Solid Tumors Receiving Chemotherapy. Supportive Care in Cancer, 16, 359-370. https://doi.org/10.1007/s00520-007-0302-3
Morita, T., Tsunoda, J., Inoue, S., et al. (1999) The Palliative Prognostic Index: A Scoring System for Survival Prediction of Terminally Ill Cancer Patients. Supportive Care in Cancer, 7, 128-133. https://doi.org/10.1007/s005200050242
Miura, T., Matsumoto, Y., Hama, T., et al. (2015) Glasgow Prognostic Score Predicts Prognosis for Cancer Patients in Palliative Settings: A Subanalysis of the Japan-Prognostic Assessment Tools Validation (J-Proval) Study. Supportive Care in Cancer, 23, 3149-3156. https://doi.org/10.1007/s00520-015-2693-x
Calaprice, A. (2011) The Ultimate Quotable Einstein. Princeton University Press, Princeton.
Szentgyorgyi, A. (1978) The Living State and Cancer. Marcel Dekker Inc., New York.
Yamagata, T., Nakamura, Y., Yamagata, Y., et al. (2003) The Pilot Trial of the Prevention of the Increase in Electrical Taste Thresholds by Zinc Containing Fluid Infusion during Chemotherapy to Treat Primary Lung Cancer. Journal of Experimental & Clinical Cancer Research, 22, 557-563.
Sieja, K. and Talerczyk, M. (2004) Selenium as an Element in the Treatment of Ovarian Cancer in Women Receiving Chemotherapy. Gynecologic Oncology, 93, 320-327. https://doi.org/10.1016/j.ygyno.2003.12.013
Freedman, M.R., King, J. and Kennedy, E. (2001) Popular Diets: A Scientific Review. Obesity Research, 9, 1S-40S. https://doi.org/10.1038/oby.2001.113
Michael, M. (2018) Comparative Studies of Energy Homeostasis in Vertebrates. Frontiers in Endocrinology and Frontiers in Neurosciesnce, 9, Article No. 291. https://doi.org/10.3389/978-2-88945-560-7
Cherif, A.O. (2012) Phytochemicals Components as Bioactive Foods. In: Rasooli, I., Ed., Bioactive Compounds in Phytomedicine, IntechOpen, London, 113-124. https://www.intechopen.com/books/bioactive-compounds-in-phytomedicine/phytochemicals-components-as-bioactive-foods
Sajjad, M., Khan, A., Ahmad, I. and Chattopadhyay, D. (2019) New Look to Phytomedicine, Advancements in Herbal Products as Novel Drug Leads. Elsevier, Amsterdam.
Pandey, M., Debnath, M., Gupta, S., et al. (2011) Phytomedicine: An Ancient Approach Turning into Future Potential Source of Therapeutics. Journal of Pharmacognosy and Phytotherapy, 3, 113-117.
Hegyi, G., Vincze, G. and Szasz, A. (2012) On the Dynamic Equilibrium in Homeostasis. Open Journal of Biophysics, 2, 64-71. https://doi.org/10.4236/ojbiphy.2012.23009
Barbosa, W.L.R., Pinto, L., Malheiros, L.C.S., Barros, P.M.S.S., de Freitas, C.B., Silva, J.O.C., Gallori, S. and Vincieri, F.F. (2012) Standardization of Herbal Drugs Derivatives with Special Reference to Brazilian Regulations. In: Rasooli, I., Ed., Bioactive Compounds in Phytomedicine, InTechOpen, London, 69-92. http://www.intechopen.com/books/bioactive-compounds-inphytomedicine/standardization-of-herbal-drugs-derivatives-with-special-reference-to-brazilian-regulations
Lampe, J.W. and Chang, J.L. (2007) Interindividual Differences in Phytochemical Metabolism and Disposition. Seminars in Cancer Biology, 17, 347-353. https://doi.org/10.1016/j.semcancer.2007.05.003
Boik, J. (2001) Natural Compounds in Cancer Therapy. Quality Books, Inc., Oregon.
Cory, H., Passarelli, S., Szeto, J., et al. (2018) The Role of Polyphenols in Human Health and Food Systems: A Mini-Review. Frontiers in Nutrition, 5, Article No. 87. https://doi.org/10.3389/fnut.2018.00087
Oparam, E.I. and Chohan, M. (2014) Culinary Herbs and Spices: Their Bioactive Properties the Contribution of Polyphenols and the Challenges in Deducing Their True Health Benefits. International Journal of Molecular Sciences, 15, 19183-19202. https://doi.org/10.3390/ijms151019183
Eloe-Fadrosh, E.A. and Rasko, D.A. (2013) The Human Microbiome from Symbiosis to Pathogenesis. Annual Review of Medicine, 64, 145-163. https://doi.org/10.1146/annurev-med-010312-133513
Martin, K.R. and Appelm, C.L. (2010) Polyphenols as Dietary Supplements: A Double-Edged Sword. Nutrition and Dietary Supplements, 2, 1-12. https://doi.org/10.2147/NDS.S6422
Hooper, B. and Frazier, R. (2012) Polyphenols in the Diet: Friend or Foe? Nutrition Bulletin, 37, 297-308. https://doi.org/10.1111/j.1467-3010.2012.02001.x
Afonso, C., Bernardo, I., Bandarra, N.M., Martins, L.L. and Cardoso, C. (2019) The Implications of Following Dietary Advice Regarding Fish Consumption Frequency and Meal Size for the Benefit (EPA+DHA and Se) versus Risk (Mehg) Assessment. International Journal of Food Sciences and Nutrition, 70, 623-637. https://doi.org/10.1080/09637486.2018.1551334
Moloudizargari, M., Mortaz, E., Asghari, M.H., et al. (2018) Effects of the Polyunsaturated Fatty Acids, EPA and DHA, on Hematological Malignancies: A Systemic Review. Oncotarget, 9, 11858-11875. https://doi.org/10.18632/oncotarget.24405
Serini, S., Fasano, E., Piccioni, E., Cittadini, A.R.M. and Calviello, G. (2011) Differential Anti-Cancer Effects of Purified EPA and DHA and Possible Mechanisms Involved. Current Medicinal Chemistry, 18, 4065-4075. https://doi.org/10.2174/092986711796957310
Buttigliero, C., Monagheddu, C., Petroni, P., et al. (2011) Prognostic Role of Vitamin D Status and Efficacy of Vitamin D Supplementation in Cancer Patients: A Systematic Review. Oncologist, 16, 1215-1227. https://doi.org/10.1634/theoncologist.2011-0098
Zhang, Y., Fang, F., Tang, J., et al. (2019) Association between Vitamin D Supplementation and Mortality: Systematic Review and Meta-Analysis. BMJ, 366, l4673. https://doi.org/10.1136/bmj.l4673
Hu, K., Callen, D.F., Li, J. and Zheng, H. (2018) Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies. Integrative Cancer Therapies, 17, 217-225. https://doi.org/10.1177/1534735417712007
Estébanez, N., Gómez, A.I., Palazuelos, C., et al. (2018) Vitamin D Exposure and Risk of Breast Cancer: A Meta-Analysis. Scientific Reports, 8, Article No. 9039. https://doi.org/10.1038/s41598-018-27297-1
Hossain, S., Beydoun, M.A., Beydoun, H.A., et al. (2019) Vitamin D and Breast Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Clinical Nutrition ESPEN, 30, 170-184. https://doi.org/10.1016/j.clnesp.2018.12.085
Zhang, L., Wang, S., Che, X. and Li, X. (2015) Vitamin D and Lung Cancer Risk: A Comprehensive Review and Meta-Analysis. Cellular Physiology & Biochemistry, 36, 299-305. https://doi.org/10.1159/000374072
Hsueh, T.Y., Baum, J.I. and Huang, Y. (2018) Effect of Eicosapentaenoic Acid and Docosahexaenoic Acid on Myogenesis and Mitochondrial Biosynthesis during Murine Skeletal Muscle Cell Differentiation. Frontiers in Nutrition, 5, Article No. 15. https://doi.org/10.3389/fnut.2018.00015
Ochi, E. and Tsuchiya, Y. (2018) Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in Muscle Damage and Function. Nutrients, 10, Article 552. https://doi.org/10.3390/nu10050552
Chow, J., Lee, S.M., Shen, Y., et al. (2010) Host-Bacterial Symbiosis in Health and Disease. Advances in Immunology, 107, 243-274. https://doi.org/10.1016/B978-0-12-381300-8.00008-3
De la Fuente, M., MacDonald, T.T. and Hermoso, M.A. (2019) Editorial: Intestinal Homeostasis and Disease: A Complex Partnership between Immune Cells, Non-Immune Cells, and the Microbiome. Frontiers in Immunology, 10, Article No. 2775. https://doi.org/10.3389/fimmu.2019.02775
Williamson, G. (2017) The Role of Polyphenols in Modern Nutrition. Nutrition Bulletin, 42, 226-235. https://doi.org/10.1111/nbu.12278
Morowitz, M.J., Carlisle, E. and Alverdy, J.C. (2011) Contributions of Intestinal Bacteria to Nutrition and Metabolism in the Critically III. Surgical Clinics of North America, 91, 771-785. https://doi.org/10.1016/j.suc.2011.05.001
Singh, A.K., Cabral, C., Kumar, R., et al. (2019) Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency. Nutrients, 11, 2216. https://doi.org/10.3390/nu11092216
Spagnuolo, C., Russo, G.L., Orhan, I.E., et al. (2015) Genistein and Cancer: Current Status, Challenges, and Future Directions. Advances in Nutrition, 6, 408-419. https://doi.org/10.3945/an.114.008052
Wang, S., Li, J., Huang, H., et al. (2009) Anti-Hepatitis B Virus Activities of Astragaloside IV Isolated from Radix Astragali. Biological and Pharmaceutical Bulletin, 32, 132-135. https://doi.org/10.1248/bpb.32.132
Wang, Y., Ren, T., Zheng, L., et al. (2016) Astragalus Saponins Inhibits Lipopolysaccharide-Induced Inflammation in Mouse Macrophages. The American Journal of Chinese Medicine, 44, 579-593. https://doi.org/10.1142/S0192415X16500324
Shahzad, M., Shabbir, A., Wojcikowski, K., et al. (2016) The Antioxidant Effects of Radix Astragali (Astragalus membranaceus and Related Species) in Protecting Tissues from Injury and Disease. Current Drug Targets, 17, 1331-1340. https://doi.org/10.2174/1389450116666150907104742
Chu, D.T., Wong, W.L. and Mavligit, G.M. (1988) Immunotherapy with Chinese Medicinal Herbs. II. Reversal of Cyclophosphamide-Induced Immune Suppression by Administration of Fractionated Astragalus membranaceus in Vivo. Journal of Clinical and Laboratory Immunology, 25, 125-129.
Martin, A.M., Yabut, J.M., Choo, J.M., et al. (2019) The Gut Microbiome Regulates Host Glucose Homeostasis via Peripheral Serotonin. PNAS, 116, 19802-19804. https://doi.org/10.1073/pnas.1909311116
Miller, L.H. and Su, X. (2011) Artemisinin: Discovery from the Chinese Herbal Garden. Cell, 146, 855-858. https://doi.org/10.1016/j.cell.2011.08.024
Zipperer, M. (2019) WHO Calls for an Immediate Halt to Provision of Single-Drug Artemisinin Malaria Pills.
Chung, V.C.H., Wu, X., Hui, E.P., et al. (2015) Effectiveness of Chinese Herbal Medicine for Cancer Palliative Care: Overview of Systematic Reviews with Meta-Analyses. Scientific Reports, 5, Article No. 18111. https://doi.org/10.1038/srep18111
Zhao, X., Zhu, Y., Hu, J., et al. (2018) Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-Mediated Aerobic Glycolysis. Scientific Reports, 8, Article No. 14517. https://doi.org/10.1038/s41598-018-31615-y
Chen, J., Xie, J., Jiang, Z., et al. (2011) Shikonin and Its Analogs Inhibit Cancer Cell Glycolysis by Targeting Tumor Pyruvate Kinase-M2. Oncogene, 30, 4297-4306. https://doi.org/10.1038/onc.2011.137
James, A.D., Richardson, D.A., Oh, I.W., et al. (2020) Cutting off the Fuel Supply to Calcium Pumps in Pancreatic Cancer Cells: Role of Pyruvate Kinase-M2 (PKM2). British Journal of Cancer, 122, 266-278. https://doi.org/10.1038/s41416-019-0675-3
Shilnikova, K., Piao, M.J., Kang, K.A., et al. (2018) Shikonin Induces Mitochondria-Mediated Apoptosis and Attenuates Epithelial-Mesenchymal Transition in Cisplatin-Resistant Human Ovarian Cancer Cells. Oncology Letter, 15, 5417-5424. https://doi.org/10.3892/ol.2018.8065
Zhang, H. and Tsao, R. (2016) Dietary Polyphenols, Oxidative Stress and Antioxidant and Anti-Inflammatory Effects. Current Opinion in Food Science, 8, 33-42. https://doi.org/10.1016/j.cofs.2016.02.002
(2013) The COVID-19 Outbreak Is an Emerging, Rapidly Evolving Situation. https://nccih.nih.gov/health/antioxidants/introduction.htm
Zhou, Y., Zheng, J., Li, Y., Xu, D.P., Li, S., Chen, Y.M., et al. (2016) Natural Polyphenols for Prevention and Treatment of Cancer. Nutrients, 8, 515. https://doi.org/10.3390/nu8080515
Fujiki, H., Sueoka, E., Watanabe, T. and Suganuma, M. (2015) Primary Cancer Prevention by Green Tea, and Tertiary Cancer Prevention by the Combination of Green Tea Catechins and Anticancer Compounds. Journal of Cancer Prevention, 20, 1-4. https://doi.org/10.15430/JCP.2015.20.1.1
Singh, K., Bhori, M., Kasu, Y.A., et al. (2018) Antioxidants as Precision Weapons in War against Cancer Chemotherapy Induced Toxicity-Exploring the Armoury of Obscurity. Saudi Pharmaceutical Journal, 26, 177-190. https://doi.org/10.1016/j.jsps.2017.12.013
Stevenson, D.E. (2012) Polyphenols as Adaptogens—The Real Mechanism of the Antioxidant Effect? In: Rasooli, I., Ed., Bioactive Compounds in Phytomedicine, InTechOpen, London, 143-162. http://www.intechopen.com/books/bioactive-compounds-in-phytomedicine/polyphenols-as-adaptogensthe-real-mechanism-of-the-antioxidant-effect
Warburg, O. (1996) Oxygen, the Creator of Differentiation, Biochemical Energetics. In: The Prime Cause and Prevention of Cancer, Academic Press, New York.
Warburg, O. (1956) On the Origin of Cancer Cells. Science, 123, 309-314. https://doi.org/10.1126/science.123.3191.309
Schulz, T.J., Thierbach, R., Voigt, A., et al. (2006) Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth. The Journal of Biological Chemistry, 281, 977-981. https://doi.org/10.1074/jbc.M511064200
Miles, K.A. and Williams, R.E. (2008) Warburg Revisited: Imaging Tumor Blood Flow and Metabolism. Cancer Imaging, 8, 81-86. https://doi.org/10.1102/1470-7330.2008.0011
Heiden, M.G.V., Cantley, L.C. and Thompson, C.B. (2009) Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science, 324, 1029-1033. https://doi.org/10.1126/science.1160809
Garber, K. (2004) Energy Boost: The Warburg Effect Returns in a New Theory of Cancer. JNCI: Journal of the National Cancer Institute, 96, 1805-1806. https://doi.org/10.1093/jnci/96.24.1805
Seyfried, T.N. and Mukherjee, P. (2005) Targeting Energy Metabolism in Brain Cancer: Review and Hypothesis. Nutrition & Metabolism, 2, 30-38. https://doi.org/10.1186/1743-7075-2-30
Xiaolong, M. and Riordan, N.H. (2006) Cancer Is a Functional Repair Tissue. Medical Hypotheses, 66, 486-490. https://doi.org/10.1016/j.mehy.2005.09.041
Wardman, P. (2001) Electron Transfer and Oxidative Stress as Key Factors in the Design of Drug Selectively Active in Hypoxia. Current Medicinal Chemistry, 8, 739-761. https://doi.org/10.2174/0929867013372959
Tracy, K., Dibling, B.C., Spike, B.T., Knabb, J.R., Schumacker, P. and MacLeod, K.F. (2007) BNIP3 Is an RB/E2F Target Gene Required for Hypoxia-Induced Autophagy. Molecular and Cellular Biology, 27, 6229-6242. https://doi.org/10.1128/MCB.02246-06
Boland, M.L., Chourasia, A.H. and Macleod, K.F. (2013) Mitochondrial Dysfunction in Cancer. Frontiers in Oncology, 3, Article No. 292. https://doi.org/10.3389/fonc.2013.00292
Wallace, D.C. (2005) Mitochondria and Cancer: Warburg Addressed. Cold Spring Harbour Symposia on Quantitative Biology, 70, 636-649. https://doi.org/10.1101/sqb.2005.70.035
Schavemaker, P.E., Boersma, A.J. and Poolman, B. (2018) How Important Is Protein Diffusion in Prokaryotes? Frontiers in Molecular Biosciences, 5, Article No. 293. https://doi.org/10.3389/fmolb.2018.00093
Wright, G.D. (2007) On the Road to Bacterial Cell Death. Cell, 130, 781-783. https://doi.org/10.1016/j.cell.2007.08.023
Petrelli, F., Ghidini, M., Ghidini, A., et al. (2019) Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Cancers, 11, Article 1174. https://doi.org/10.3390/cancers11081174
Kim, H., Lee, J.E., Hong, S.H., et al. (2019) The Effect of Antibiotics on the Clinical Outcomes of Patients with Solid Cancer Undergoing Immune Checkpoint Inhibitor Treatment: A Retrospective Study. BMC Cancer, 19, Article No. 21100. https://doi.org/10.1186/s12885-019-6267-z
McKee, A., Hall, L.J. and Robinson, S.D. (2019) The Microbiota, Antibiotics and Breast Cancer. Breast Cancer Management, 8, BMT29. https://doi.org/10.2217/bmt-2019-0015
Bordonaro, M. (2018) Hypothesis: Cancer Is a Disease of Evolved Trade-Offs between Neoplastic Virulence and Transmission. Journal of Cancer, 9, 1707-1724. https://doi.org/10.7150/jca.24679
Medicinal Mushrooms (PDQ ® )-Health Professional Version. https://www.cancer.gov/about-cancer/treatment/cam/hp/mushrooms-pdq
Wasser, S.P. (2014) Medicinal Mushroom Science: Current Perspectives, Advances, Evidences, and Challenges. Biomedical Journal, 37, 345-356. https://doi.org/10.4103/2319-4170.138318
Ng, T.B. (1998) A Review of Research on the Protein-Bound Polysaccharide (Polysaccharopeptide, PSP) from the Mushroom Coriolus Versicolor (Basidiomycetes: Polyporaceae). General Pharmacology, 30, 1-4. https://doi.org/10.1016/S0306-3623(97)00076-1
Konno, S. (2009) Synergistic Potentiation of D-Fraction with Vitamin C as Possible Alternative Approach for Cancer Therapy. International Journal of General Medicine, 2, 91-108. https://doi.org/10.2147/IJGM.S5498
Masuda, Y., Inoue, H., Ohta, H., et al. (2013) Oral Administration of Soluble B-Glucans Extracted from Grifola Frondosa Induces Systemic Antitumor Immune Response and Decreases Immunosuppression in Tumor-Bearing Mice. International Journal of Cancer, 133, 108-120. https://doi.org/10.1002/ijc.27999
Shomori, K., Yamamoto, M., Arifuku, I., Teramachi, K. and Ito, H. (2009) Antitumor Effects of a Water-Soluble Extract from Maitake (Grifola frondosa) on Human Gastric Cancer Cell Lines. Oncology Reports, 22, 615-620. https://doi.org/10.3892/or_00000480
Masuda, Y., Murata, Y., Hayashi, M. and Nanba, H. (2008) Inhibitory Effect of Mdfraction on Tumor Metastasis: Involvement of NK Cell activation and Suppression of Intercellular Adhesion Molecule (ICAM)-1 Expression in Lung Vascular Endothelial Cells. Biological and Pharmaceutical Bulletin, 31, 1104-1108. https://doi.org/10.1248/bpb.31.1104
Masuda, Y., Nakayama, Y., Tanaka, A., Naito, K. and Konishi, M. (2017) Antitumor Activity of Orally Administered Maitake Α-Glucan by Stimulating Antitumor Immune Response in Murine Tumor. PLOS ONE, 12, e0173621. https://doi.org/10.1371/journal.pone.0173621
Zhao, F., Zhao, J., Song, L., Zhang, Y.Q., Guo, Z. and Yang, K.H. (2017) The Induction of Apoptosis and Autophagy in Human Hepatoma SMMC-7721 Cells by Combined Treatment with Vitamin C and Polysaccharides Extracted from Grifola Frondosa. Apoptosis, 22, 1461-1472. https://doi.org/10.1007/s10495-017-1421-z
Lin, H., She Y.-H., Cassileth, B.R. et al. (2004) Maitake Beta-Glucan MD-Fraction Enhances Bone Marrow Colony Formation and Reduces Doxorubicin Toxicity in Vitro. International Immunopharmacology, 4, 91-99. https://doi.org/10.1016/j.intimp.2003.10.012
Dai, X., Stanilka, J.M., Rowe, C.A., Esteves, E.A., et al. (2015) Consuming Lentinula Edodes (Shiitake) Mushrooms Daily Improves Human Immunity: A Randomized Dietary Intervention in Healthy Young Adults. Journal of the American College of Nutrition, 34, 478-487. https://doi.org/10.1080/07315724.2014.950391
Ina, K., Furuta, R., Kataoka, T., et al. (2016) Chemo-Immunotherapy Using Lentinan for the Treatment of Gastrick Cancer with Liver Metastases. Medical Sciences, 4, Article 8. https://doi.org/10.3390/medsci4020008
Rincão, V.P., Yamamoto, K.A., Ricardo, N.M., et al. (2012) Polysaccharide and Extracts from Lentinula Edodes: Structural Features and Antiviral Activity. Virology Journal, 9, Article No. 37. https://doi.org/10.1186/1743-422X-9-37
Kim, S.P., Park, S.O., Lee, S.J., Nam, S.H. and Friedman, M. (2014) A Polysaccharide Isolated from the Liquid Culture of Lentinus Edodes (Shiitake) Mushroom Mycelia Containing Black Rice Bran Protects Mice against Salmonellosis through Upregulation of the Th1 Immune Reaction. Journal of Agricultural and Food Chemistry, 62, 2384-2391. https://doi.org/10.1021/jf405223q
Tanigawa, K., Itoh, Y. and Kobayashi, Y. (2016) Improvement of QOL and Immunological Function with Lentinula Edodes Mycelia in Patients Undergoing Cancer Immunotherapy: An Open Pilot Study. Alternative Therapies in Health and Medicine, 22, 36-42.
Jin, X., Ruiz, B.J., Sze, D.M.Y. and Chan, G.C.F. (2016) Ganoderma Lucidum (Reishi Mushroom) for Cancer Treatment (Review). Cochrane Database of Systematic Reviews, No. 4, CD007731. https://doi.org/10.1002/14651858.CD007731.pub3
Wang, C., Shi, S., Chen, Q., et al. (2018) Antitumor and Immunomodulatory Activities of Ganoderma lucidum Polysaccharides in Glioma-Bearing Rats. Integrative Cancer Therapies, 17, 674-683. https://doi.org/10.1177/1534735418762537
Gill, S.K. and Rieder, M.J. (2008) Toxicity of a Traditional Chinese Medicine, Ganoderma lucidum, in Children with Cancer. Canadian Journal of Clinical Pharmacology, 15, e275-e285.
Yuen, M.F., Ip, P., Ng, W.K. and Lai, C.L. (2004) Hepatotoxicity Due to a Formulation of Ganoderma lucidum (Lingzhi). Journal of Hepatology, 41, 686-687. https://doi.org/10.1016/j.jhep.2004.06.016
Wanmuang, H., Leopairut, J., Kositchaiwat, C., Wananukul, W. and Bunyaratvej, S. (2007) Fatal Fulminant Hepatitis Associated with Ganoderma lucidum (Lingzhi) Mushroom Powder. Journal of the Medical Association of Thailand, 90, 179-181.
Bhushan, A. and Kulshreshtha, M. (2018) The Medicinal Mushroom Agaricus Bisporus: Review of Phytopharmacology and Potential Role in the Treatment of Various Diseases. Journal of Nature and Science of Medicine, 1, 4-9.
Vetter, J. (2003) Chemical Composition of Fresh Conserved Agaricus bisporus Mushroom. European Food Research and Technology, 217, 10-12. https://doi.org/10.1007/s00217-003-0707-2
Firenzuoli, F., Gori, L. and Lombardo, G. (2007) The Medicinal Mushroom Agaricus Blazei Murrill: Review of Literature and Pharmaco-Toxicological Problems. eCAM, 5, 3-15. https://doi.org/10.1093/ecam/nem007
Piska, K., Muszynska, B. and Ziaja, K. (2017) Edible Mushroom Pleurotus ostreatus (Oyster Mushroom)—Its Dietary Significance and Biological Activity. Acta Scientiarum Polonorum Hortorum Cultus, 16, 151-161.
Blagodatski, A., Yatsunskaya, M., Mikhailova, V., et al. (2018) Medicinal Mushrooms as an Attractive New Source of Natural Compounds for Future Cancer Therapy. Oncotarget, 9, 29259-29274. https://doi.org/10.18632/oncotarget.25660
Xu, T., Beelman, R.B. and Lambert, J.D. (2012) The Cancer Preventive Effects of Edible Mushrooms. Anti-Cancer Agents in Medicinal Chemistry, 12, 1255-1263. https://doi.org/10.2174/187152012803833017
Horneber, M.A., Bueschel, G., Huber, R., et al. (2008) Mistletoe Therapy in Oncology. Cochrane Database of Systematic Reviews, No. 2, CD003297. https://doi.org/10.1002/14651858.CD002833.pub2
Ostermann, T., Raak, C. and Bussing, A. (2009) Survival of Cancer Patients Treated With Mistletoe Extract (Iscador): A Systematic Literature Review. BMC Cancer, 9, Article No. 451. https://doi.org/10.1186/1471-2407-9-451
Melzer, J., Iten, F., Hostanska, K., et al. (2009) Efficacy and Safety of Mistletoe Preparations (Viscum album) for Patients with Cancer Diseases. A Systematic Review. Forschende Komplementärmedizin, 16, 217-226. https://doi.org/10.1159/000226249
Kleijnen, J. and Knipschild, P. (1994) Mistletoe Treatment for Cancer Review of Controlled Trials in Humans. Phytomedicine, 1, 255-260. https://doi.org/10.1016/S0944-7113(11)80073-5
Lyu, S.Y. and Park, W.B. (2007) Effects of Korean Mistletoe Lectin (Viscum album Coloratum) on Proliferation and Cytokine Expression in Human Peripheral Blood Mononuclear Cells and T-Lymphocytes. Archives of Pharmacal Research, 30, 1252-1264. https://doi.org/10.1007/BF02980266
Witters, L.A. (2001) The Blooming of the French Lilac. The Journal of Clinical Investigation, 108, 1105-1107. https://doi.org/10.1172/JCI14178
Werner, E. and Bell, J. (1922). The Preparation of Methylguanidine, and of Ββ-Dimethylguanidine by the Interaction of Dicyandiamide, and Methylammonium and Dimethylammonium Chlorides Respectively. Journal of the Chemical Society, Transactions, 121, 1790-1795. https://doi.org/10.1039/CT9222101790
Zi, F., Zi, H., Li, Y., et al. (2018) Metformin and Cancer: An Existing Drug for Cancer Prevention and Therapy (Review). Oncology Letters, 15, 683-690. https://doi.org/10.3892/ol.2017.7412
Gonzalez-Aungulo, A.M. and Meric-Bernstam, F. (2010) Metformin: A Therapeutic Opportunity in Breast Cancer. Clinical Cancer Research, 16, 1695-1700. https://doi.org/10.1158/1078-0432.CCR-09-1805
Li, C., Xue, Y., Xi, Y.R. and Xie, K. (2017) Progress in the Application and Mechanism of Metformin in Treating Non-Small Cell Lung Cancer (Review). Oncology Letters, 13, 2873-2880. https://doi.org/10.3892/ol.2017.5862
Rosilio, C., Ben-Sahra, I., Bost, F. and Peyron, J.F. (2014) Metformin: A Metabolic Disruptor and Anti-Diabetic Drug to Target Human Leukemia. Cancer Letters, 246, 188-196. https://doi.org/10.1016/j.canlet.2014.01.006
Andrzejewski, S., Gravel, S.P., Pollak, M. and St-Pierre, J. (2014) Metformin Directly Acts on Mitochondria to Alter Cellular Bioenergetics. Cancer and Metabolism, 2, Article No. 12. https://doi.org/10.1186/2049-3002-2-12
Devasagayam, T.P., Tilak, J.C., Boloor, K.K., Sane, K.S., Ghaskadbi, S.S. and Lele, R.D. (2004) Free Radicals and Antioxidants in Human Health: Current Status and Future Prospects. The Journal of the Association of Physicians of India, 52, 794-804.
Sing, K., Bhori, M., Kasu, Y.A., et al. (2018) Antioxidants as Precision Weapons in War against Cancer Chemotherapy Induced Toxicity—Exploring the Armoury of Obscurity. Saudy Pharmaceutical Journal, 26, 177-190. https://doi.org/10.1016/j.jsps.2017.12.013
Masri, O.A., Chalhoub, J.M. and Sharara, A.I. (2015) Role of Vitamins in Gastrointestinal Diseases. World Journal of Gastroenterology, 21, 5191-5209. https://doi.org/10.3748/wjg.v21.i17.5191
Funk, C. (1912) The Etiology of the Deficiency Diseases. Journal of State Medicine, 20, 341-368.
Piro, A., Tagarelli, G., Lagonia, P., et al. (2010) Casimir Funk: His Discovery of the Vitamins and Their Deficiency Disorders. Annals of Nutrition and Metabolism, 57, 85-88. https://doi.org/10.1159/000319165
Thyagarajan, A. and Sahu, R.P. (2018) Potential Contributions of Antioxidants to Cancer Therapy: Immunomodulation and Radiosensitization. Integrative Cancer Therapies, 17, 210-216. https://doi.org/10.1177/1534735416681639
Antioxidants: In Depth. https://nccih.nih.gov/health/antioxidants/introduction.htm
SzentGyörgyi, A. (1937) Oxidation, Energy Transfer, and Vitamins. Nobel Lecture.
Stahelin, H.B. (1988) Vitamins and Cancer, Recent Results. In: Senn, H.J., Glaus, A. and Schmid, L., Eds., Supportive Care in Cancer Patients. Recent Results in Cancer Research, Vol. 108, Springer-Verlag, Berlin, 227-234. https://doi.org/10.1007/978-3-642-82932-1_28
Cameron, E., Pauling, L. (1974) The Orthomolecular Treatment of Cancer. I. The Role of Ascorbic Acid in Host Resistance. Chemico-Biological Interactions, 9, 273-283. https://doi.org/10.1016/0009-2797(74)90018-0
Cameron, E. and Pauling, L. (1976) Supplemental Ascorbate in the Supportive Treatment of Cancer: Prolongation of Survival Times in Terminal Human Cancer. Proceedings of the National Academy of Sciences of the United States of America, 73, 3685-3689. https://doi.org/10.1073/pnas.73.10.3685
Cameron, E. and Campbell, A. (1991) Innovation vs. Quality Control: An “Unpublishable” Clinical Trial of Supplemental Ascorbate in Incurable Cancer. Medical Hypotheses, 36, 185-189. https://doi.org/10.1016/0306-9877(91)90127-K
Cameron, E. and Pauling, L. (1978) Supplemental Ascorbate in the Supportive Treatment of Cancer: Reevaluation of Prolongation of Survival Times in Terminal Human Cancer. Proceedings of the National Academy of Sciences of the United States of America, 75, 4538-4542. https://doi.org/10.1073/pnas.75.9.4538
Creagan, E.T., Moertel, C.G., O’Fallon, J.R., et al. (1979) Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced Cancer. A Controlled Trial. New England Journal of Medicine, 301, 687-690. https://doi.org/10.1056/NEJM197909273011303
Tschetter, L., et al. (1983) A Community-Based Study of Vitamin C (Ascorbic Acid) in Patients with Advanced Cancer. Proceedings of the American Society of Clinical Oncology, 2, Article No. 92.
Shenoy, N., Creagan, E., Witzig, T. and Levine, M. (2018) Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly. Cancer Cell, 34, 700-706. https://doi.org/10.1016/j.ccell.2018.07.014
Reczek, C.R. and Chandel, N.S. (2015) Revisiting Vitamin C and Cancer. Science, 350, 1317-1318. https://doi.org/10.1126/science.aad8671
Hoffer, L.J., Levine, M., Assouline, S., et al. (2008) Phase I Clinical Trial of I.V. Ascorbic Acid in Advanced Malignancy. Annals of Oncology, 19, 1969-1974. https://doi.org/10.1093/annonc/mdn377
Stephenson, C.M., Levin, R.D., Spector, T., et al. (2013) Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of High-Dose Intravenous Ascorbic Acid in Patients with Advanced Cancer. Cancer Chemotherapy and Pharmacology, 72, 139-146. https://doi.org/10.1007/s00280-013-2179-9
Riordan, H.D., Casciari, J.J., Gonzalez, M.J., et al. (2005) A Pilot Clinical Study of Continuous Intravenous Ascorbate in Terminal Cancer Patients. Puerto Rico Health Sciences Journal, 24, 269-276.
Carr, A.C., Vissers, M.C.M. and Cook, J. (2014) Relief from Cancer Chemotherapy Side Effects with Pharmacologic Vitamin C. New Zealand Medical Journal, 127, 66-70.
Ma, Y., Chapman, J., Levine, M., Polireddy, K., Drisko, J. and Chen, Q. (2014) High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy. Science Translational Medicine, 6, 222-218. https://doi.org/10.1126/scitranslmed.3007154
Monti, D.A., Mitchell, E., Bazzan, A.J., Littman, S., Zabrecky, G., Yeo, C.J., Pillai, M.V., Newberg, A.B., Deshmukh, S. and Levine, M. (2012) Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer. PLOS ONE, 7, e29794. https://doi.org/10.1371/journal.pone.0029794
Welsh, J.L., Wagner, B.A., van’t Erve, T.J., et al. (2013) Pharmacological Ascorbate with Gemcitabine for the Control of Metastatic and Node-Positive Pancreatic Cancer (PACMAN): Results from a Phase I Clinical Trial. Cancer Chemotherapy and Pharmacology, 71, 765-775. https://doi.org/10.1007/s00280-013-2070-8
Ou, J., Zhu, X., Lu, Y., et al. (2017) The Safety and Pharmacokinetics of High Dose Intravenous Ascorbic Acid Synergy with Modulated Electrohyperthermia in Chinese Patients with Stage III-IV Non-Small Cell Lung Cancer. European Journal of Pharmaceutical Sciences, 109, 412-418. https://doi.org/10.1016/j.ejps.2017.08.011
Carr, A.C., Vissers, M.C.M. and Cook, J. (2014) The Effect of Intravenous Vitamin C on Cancer—And Chemotherapy-Related Fatigue and Quality of Life. Frontiers in Oncology, 4, Article No. 283. https://doi.org/10.3389/fonc.2014.00283
Vollbracht, C., Schneider, B., Leendert, V., Weiss, G., Auerbach, L. and Beuth, J. (2011) Intravenous Vitamin C Administration Improves Quality of Life in Breast Cancer Patients during Chemo-/Radiotherapy and Aftercare: Results of a Retrospective, Multicentre. Epidemiological Cohort Study in Germany, in Vivo, 25, 983-990.
Da Mata, A.M.O.F., De Carvalho, R.M., De Alencar, M.V.O.B., Cavalcante, A.M.D.C.M. and Da Silva, B.B. (2016) Ascorbic Acid in the Prevention and Treatment of Cancer. Revista da Associação Médica Brasileira, 62, 680-686. https://doi.org/10.1590/1806-9282.62.07.680
Mikirova, N., Casciari, J., Rogers, A. and Taylor, P. (2012) Effect of High-Dose Intravenous Vitamin C on Inflammation in Cancer Patients. Journal of Translational Medicine, 10, Article No. 189. https://doi.org/10.1186/1479-5876-10-189
Barrett, S. (2011, October 3) High Doses of Vitamin C Are Not Effective as a Cancer Treatment. https://www.quackwatch.org/01QuackeryRelatedTopics/Cancer/c.html
Vissers, M.C.M. and Das, A.B. (2018) Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence. Frontiers in Physiology, 9, Article No. 809. https://doi.org/10.3389/fphys.2018.00809
Bast, A. and Haenen, G.R.M.M. (2013) Ten Misconceptions about Antioxidants. Trends in Pharmacological Sciences, 34, 430-436. https://doi.org/10.1016/j.tips.2013.05.010
Podmore, I.D., Griffiths, H.R., Herbert, K.E., et al. (1998) Vitamin C Exhibits Pro-Oxidant Properties. Nature, 392, Article No.559. https://doi.org/10.1038/33308
Myung, S.K. and Yang, H.J. (2013) Efficacy of Vitamin and Antioxidant Supplements in Prevention of Esophageal Cancer: Meta-Analysis of Randomized Controlled Trials. Journal of Cancer Prevention, 18, 135-143. https://doi.org/10.15430/JCP.2013.18.2.135
Jain, A., Tiwari, A., Verma, A., et al. (2017) Vitamins for Cancer Prevention and Treatment: An Insight. Current Molecular Medicine, 17, 321-340. https://doi.org/10.2174/1566524018666171205113329
Mut-Salud, N., álvarez, P.J., Garrido, J.M., et al. (2016) Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results. Oxidative Medicine and Cellular Longevity, 2016, Article ID: 6719534. https://doi.org/10.1155/2016/6719534
Watson, J. (2013) Oxidants, Antioxidants and the Current Incurability of Metastatic Cancers. Open Biology, 3, Article ID: 120144. https://doi.org/10.1098/rsob.120144
(2013) James Watson Hypothesis Links Cancer to Antioxidants. https://www.genengnews.com/topics/omics/james-watson-hypothesis-links-cancer-to-antioxidants
Meffert, H. (2008) Antioxidants—Friend or Foe? GMS German Medical Science, 6, Doc09. https://www.egms.de/static/en/journals/gms/2008-6/000054.shtml
Bjelakovic, G., Nikolova, D., et al. (2007) Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-Analysis. JAMA, 297, 842-857. https://doi.org/10.1001/jama.297.8.842
Bjelakovic, G., Nikolova, D., Gluud, L.L., et al. (2007) Review: Antioxidant Supplements for Primary and Secondary Prevention Do Not Decrease Mortality. JAMA, 297, 842-857. https://doi.org/10.1001/jama.297.8.842
Bjelakovic, G., Nikolova, D. and Gluud, C. (2013) Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm? PLOS ONE, 8, e74558. https://doi.org/10.1371/journal.pone.0074558
Bjelakovic, G., Nikolova, D. and Simonetti, R.G. (2008) Systematic Review—Primary and Secondary Prevention of Gastrointestinal Cancers with Antioxidant Supplements. Alimentary Pharmacology & Therapeutics, 28, 689-703. https://doi.org/10.1111/j.1365-2036.2008.03785.x
Dotan, Y., Pinchuk, I., Lichtenberg, D., et al. (2009) Decision Analysis Supports the Paradigm That Indiscriminate Supplementation of Vitamin E Does More Harm than Good. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 1304-1309. https://doi.org/10.1161/ATVBAHA.108.178699
Akanji, M.A., Fatinukun, H.D. and Rotini, D.E. (2020) The Two Sides of Dietary Antioxidants in Cancer Therapy. InTech Open, 1-16. https://www.intechopen.com/chapters/66504
Acharya, A., Das, I., Chandhok, D. and Saha, T. (2010) Redox Regulation in Cancer: A Double-Edged Sword with Therapeutic Potential. Oxidative Medicine and Cellular Longevity, 3, 23-34. https://doi.org/10.4161/oxim.3.1.10095
Aasdi-Samani, M., Farkhad, N.K., Mahmoudian-Sani, M.R., et al. (2019) Antioxidants as a Double-Edged Sword in the Treatment of Cancer. In: Shalaby, E., Ed., Antioxidants, IntechOpen, London. https://www.intechopen.com/chapters/66504
Conklin, K.A. (2004) Cancer Chemotherapy and Antioxidants. The Journal of Nutrition, 134, 3201S-3204S. https://doi.org/10.1093/jn/134.11.3201S
Sznarkowska, A., Kostecka, A., Meller, K. and Bielawski, K.P. (2017) Inhibition of Cancer Antioxidant Defense by Natural Compounds. Oncotarget, 8, 15996-16016. https://doi.org/10.18632/oncotarget.13723
Szasz, O., Szigeti, G.P. and Szasz, A. (2017) On the Self-Similarity in Biologyical Processes. OJBIPHY, 7, 183-196. https://doi.org/10.4236/ojbiphy.2017.74014
Szasz, O., Szigeti, G.P. and Szasz, A. (2019) The Intrinsic Self-Time of Biosystems. OJBIPHY, 9, 131-145.
Kovacic, P. and Osuna, J.A. (2000) Mechanisms of Anti-Cancer Agents: Emphasis on Oxidative Stress and Electron Transfer. Current Pharmaceutical Design, 6, 277-309. https://doi.org/10.2174/1381612003401046
Mamede, A.C., Tavares, S.D., Abrantes, A.M., et al. (2011) Role of Vitamins in Cancer: A Review. Nutrition and Cancer, 63, 479-494. https://doi.org/10.1080/01635581.2011.539315
Teitelbaum, H.A. (1956) Homeostasis and Personality. Archives of Neurology & Psychiatry, 76, 317-324. https://doi.org/10.1001/archneurpsyc.1956.02330270089016
Stagner, R. (1951) Homeostasis as a Unifying Concept in Personality Theory. Psychological Review, 58, 5-17. https://doi.org/10.1037/h0063598
Cummins, R.A., Gullone, E. and Lau, A.L.D. (2002) A Model of Subjective Well-Being Homeostasis: The Role of Personality. In: Gullone, E. and Cummins, R.A., Eds., The Universality of Subjective Wellbeing Indicators, Social Indicators Research Series, Vol. 16, Springer, Dordrecht, 7-46. https://doi.org/10.1007/978-94-010-0271-4
Dicks, L.M.T., Geldenhuys, J., Mikkelsen, L.S., et al. (2018) Our Gut Microbiota: A Long Walk to Homeostasis. Benef Microbes, 9, 3-20. https://doi.org/10.3920/BM2017.0066
Pédron, T., Nigro, G. and Sansonetti, P.J. (2016) From Homeostasis to Pathology: Decrypting Microbe-Host Symbiotic Signals in the Intestinal Crypt. Philosophical Transactions of the Royal Society B, 371, Article ID: 20150500. https://doi.org/10.1098/rstb.2015.0500
Armour, C.R., Nayfach, S., Pollard, K.S. and Sharpton, T.J. (2019) A Metagenomic Meta-Analysis Reveals Functional Signatures of Health and Disease in the Human Gut Microbiome. mSystems, 4, e00332-18. https://doi.org/10.1128/mSystems.00332-18
Huybrechts, I., Zouiouich, S., Loobuyck, A., et al. (2020) The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies. Cancer Epidemiology, Biomarkers & Prevention, 10, 1856-1868. https://doi.org/10.1158/1055-9965.EPI-20-0288
Gethings-Behncke, C., Coleman, H.G., Jordao, H.W.T., et al. (2020) Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-Analysis. Cancer Epidemiology, Biomarkers & Prevention, 3, 539-548. https://doi.org/10.1158/1055-9965.EPI-18-1295
Brusselaers, N., Shrestha, S., van de Wijgert, J. and Verstraelen, H. (2019) Vaginal Dysbiosis and the Risk of Human Papillomavirus and Cervical Cancer: Systematic Review and Meta-Analysis. American Journal of Obstetrics and Gynecology, 221, 9-18.e8. https://doi.org/10.1016/j.ajog.2018.12.011
Yang, J.J., Yu, D., Xiang, Y.B., et al. (2020) Association of Dietary Fiber and Yogurt Consumption with Lung Cancer Risk: A Pooled Analysis. JAMA Oncology, 6, e194107. https://doi.org/10.1001/jamaoncol.2019.4107
Perrone, A.M., Pirovano, C., Borghese, G., et al. (2019) Palliative Electrochemotherapy in Vulvar Carcinoma: Preliminary Results of the ELECHTRA (Electrochemotherapy Vulvar Cancer) Multicenter Study. Cancers, 11, 657. https://doi.org/10.3390/cancers11050657
Mazzocca, A. (2019) The Systemic-Evolutionary Theory of the Origin of Cancer (SETOC): A New Interpretative Model of Cancer as a Complex Biological System. International Journal of Molecular Sciences, 20, Article 4885. https://doi.org/10.3390/ijms20194885
Sharma, V. (2016) The Application of Chaos Theory and Fractal Mathematics to the Study of Cancer Evolution: Placing Metabolism and Immunity Centre Stage. Medical Research Archives, 4, 1-12. https://doi.org/10.18103/mra.v4i6.717
Balmain, A., Gray, J. and Ponder, B. (2014) The Genetics and Genomics of Cancer. Nature Genetics, 33, 238-244. https://doi.org/10.1038/ng1107
Szigeti, G.P., Szasz, O. and Hegyi, G. (2017) Connections between Warburg’s and Szentgyorgyi’s Approach about the Causes of Cancer. Journal of Neoplasm, 1, Article No. 8. http://neoplasm.imedpub.com/connections-between-warburgs-and-szentgyorgyis-approach-about-thecauses-of-cancer.pdf
Hanahan, D. and Weinberg, R.A. (2000) The Hallmarks of Cancer. Cell, 100, 57-70. https://doi.org/10.1016/S0092-8674(00)81683-9
Dyas, F.G. (1928) Chronic Irritation as a Cause of Cancer. JAMA, 90, 457. https://doi.org/10.1001/jama.1928.92690330003008c
Dvorak, H.F. (1986) Tumors: Wounds that Do Not Heal, Similarities between Tumor Stroma Generation and Wound Healing. The New England Journal of Medicine, 315, 1650-1659. https://doi.org/10.1056/NEJM198612253152606
Platz, E.A. and De Marzo, A.M. (2004) Epidemiology of Inflammation and Prostate Cancer. The Journal of Urology, 171, S36-S40. https://doi.org/10.1097/01.ju.0000108131.43160.77
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. https://doi.org/10.1016/j.cell.2011.02.013
Punyiczki, M. and Fesus, L. (1998) Heat Shock and Apoptosis: The Two Defense Systems of the Organisms May Have Overlapping Molecular Elements. Annals of the New York Academy of Sciences, 951, 67-74. https://doi.org/10.1111/j.1749-6632.1998.tb08978.x
Popkin, G. (2011) Physics Sheds Light on Cancer and Bacteria Evolution. APC News, Vol. 20, No. 5. https://www.aps.org/publications/apsnews/201105/cancerbacteria.cfm
Trigos, A.S., Pearson, R.B., Paenfuss, A.T., et al. (2018) How the Evolution of Multicellularity Set the Stage for Cancer. British Journal of Cancer, 118, 145-152. https://doi.org/10.1038/bjc.2017.398
Trigos, A.S., Pearson, R.B., Papenfuss, A.T., et al. (2016) Altered Interactions between Unicellular and Multicellular Genes Drive Hallmarks of Transformation in a Diverse Range of Solid Tumors. PNAS, 114, 6406-6411. https://doi.org/10.1073/pnas.1617743114
Aktipis, C.A., Bobby, A.M., Jansen, G., et al. (2015) Cancer across the Tree of Life: Cooperation and Cheating in Multicellularity. Philosophical Transactions of the Royal Society B, 370, Article ID: 20140219. https://doi.org/10.1098/rstb.2014.0219
Jezequel, P. and Campone, M. (2018) Comment on “How the Evolution of Multicellularity Set the Stage for Cancer”. British Journal of Cancer, 119, 133-134. https://doi.org/10.1038/s41416-018-0091-0
Szentgyorgyi, A. (1998) Electronic Biology and Cancer. Marcel Dekker, New York.
Kirson, E.D., Gurvich, Z., Schneiderman, R., et al. (2004) Disruption of Cancer Cell Replication by Alternating Electric Fields. Cancer Research, 64, 3288-3295. https://doi.org/10.1158/0008-5472.CAN-04-0083
Vincze, G., Sziget, G.P. and Szasz, A. (2016) Reorganization of the Cytoskeleton. Journal of Advances in Biology, 9, 1872-1882. https://cirworld.com/index.php/jab/article/view/4059
Springer, M. and Paulsson, J. (2006) Harmonies from Noise. Nature, 439, 27-28. https://doi.org/10.1038/439027a
West, J.B. (2013) Fractal Physiology and Chaos in Medicine. World Scientific, Singapore. https://doi.org/10.1142/8577
Szasz, O., Vincze, G., Szigeti, G.P. and Szasz, A. (2017) Intrinsic Noise Monitoring of Complex Systems. OJBIPHY, 7, 197-215. https://doi.org/10.4236/ojbiphy.2017.74015
Friedman, E., Verderame, M., Winawer, S. and Pollack, R. (1984) Actin Cytoskeletal Organization Loss in the Benign-to-Malignant Tumor Transition in Cultured Human Colonic Epithelial Cells. Cancer Research, 44, 3040-3050.
Suresh, S. (2007) Biomechanics and Biophysics of Cancer Cells. Acta Biomaterialia, 3, 413-438. https://doi.org/10.1016/j.actbio.2007.04.002
Plodinec, M., Loparic, M., Monnier, C.A., et al. (2012) The Nanomechanical Signature of Breast Cancer. Nature Nanotechnology, 7, 757-765. http://www.nature.com/nnano/journal/v7/n11/full/nnano.2012.167.html?WT.ec_id=NNANO-201211
Wirts, D., Konstantopoulos, K. and Searson, P.C. (2011) The Physics of Cancer: The Role of Physical Interactions and Mechanical Forces in Metastasis. Nature Reviews, Cancer, 11, 512-518. https://doi.org/10.1038/nrc3080
Uklrich, T.A., Pardo, E.M.D.J. and Kumar, S. (2009) The Mechanical Rigidity of the Extracellular Matrix Regulates the Structure, Motility, and Proliferation of Glioma Cells. Cancer Research, 69, 4167-4175. https://doi.org/10.1158/0008-5472.CAN-08-4859
Hameroff, S.R. (1988) Coherence in the Cytoskeleton: Implications for Biological Information Processing. In: Froelich, H., Ed., Biological Coherence and Response to External Stimuli, Springer Verlag, Berlin, 242-266. https://doi.org/10.1007/978-3-642-73309-3_14
Janmey, P. (1995) Cell Membranes and the Cytoskeleton. In: Lipowsky, R. and Sackinan, E., Eds., Handbook of Biological Physics, Volume I, Elsevier Science, Amsterdam, 805-849. https://doi.org/10.1016/S1383-8121(06)80010-2
Del, Giudice, E., et al. (1988) Structures, Correlations and Electroimagnetic Interactions in Living Matter. In: Froelich, H., Ed., Biological Coherence and Response to External Stimuli, Springer Verlag, Berlin, 49-64. https://doi.org/10.1007/978-3-642-73309-3_3
Cho, M.R., Thatte, H.S., Lee, R.C., et al. (1996) Reorganization of Microfilament Structure Induced by Ac Electric Fields. FASEB Journal, 10, 1552-1558. https://doi.org/10.1096/fasebj.10.13.8940302
Agmon, N. (1995) The Grotthuss Mechanism. Chemical Physics Letters, 244, 456-462. https://doi.org/10.1016/0009-2614(95)00905-J
Markovitch, O. and Agmon, N. (2007) Structure and Energetics of the Hydronium Hhydration Shells. The Journal of Physical Chemistry A, 111, 2253-2256. https://doi.org/10.1021/jp068960g
Jackson, M.D.B., Duran-Nebreda, S. and Bassel, G.W. (2017) Network-Based Approaches to Quantify Multicellular Development. Journal of the Royal Society Interface, 14, Article ID: 20170484. https://doi.org/10.1098/rsif.2017.0484
Adami, C. (1995) Self-Organized Criticality in Living Systems. Physics Letters A, 203, 29-32. https://doi.org/10.1016/0375-9601(95)00372-A
Seo, H., Kim, W., Lee, J., et al. (2013) Network-Based Approaches for Anticancer Therapy (Review). International Journal of Oncology, 43, 1737-1744. https://doi.org/10.3892/ijo.2013.2114
Barabasi, A.L., Menichetti, G. and Loscalzo, J. (2019) The Unmapped Chemical Complexity of Our Diet. Nature Food, 1, 33-37. https://doi.org/10.1038/s43016-019-0005-1
Albert, R. (2005) Scale-Free Networks in Cell Biology. Journal of Cell Science, 118, 4947-4957. https://doi.org/10.1242/jcs.02714
Bak, P., Chen, K. and Creutz, M. (1989) Self-Organized Criticality in the “Game of Life”. Nature, 342, 780-782. https://doi.org/10.1038/342780a0
Bak, P., Tang, C. and Wiesenfeld, K. (1987) Self-Organized Criticality: An Explanation of 1/f Noise. Physical Review Letters, 59, 381-384. https://doi.org/10.1103/PhysRevLett.59.381
Szendro, P., Vincze, G. and Szasz, A. (2001) Pink Noise Behaviour of the Bio-Systems. European Biophysics Journal, 30, 227-231. http://www.ncbi.nlm.nih.gov/pubmed/11508842
Szendro, P., Vincze, G. and Szasz, A. (2001) Bio-Response to White Noise Excitation. Electro- and Magnetobiology, 20, 215-229. http://www.tandfonline.com/doi/abs/10.1081/JBC-100104145?journalCode=iebm19
Szasz, A. (2014) Oncothermia: Complex Therapy by EM and Fractal Physiology. 31th URSI General Assembly and Scientific Symposium (URSI GASS), Beijing, 16-23 August 2014, 1-4. https://ieeexplore.ieee.org/document/6930100
Szasz, A., Vincze, G., Szigeti, G. and Szasz, O. (2017) Internal Charge Redistribution and Currents in Cancerous Lesions. Journal of Advances in Biology, 10, 2061-2079.
Lineweaver, C.H., Davies, P.C.W. and Vincent, M.D. (2014) Targeting Cancer’s Weaknesses (Not Its Strengths): Therapeutic Strategies Suggested by the Atavistic Model. Bioessays, 36, 827-835. https://doi.org/10.1002/bies.201400070
Reid, B., McCaig, C.D., Zhao, M., et al. (2005) Wound Healing in Rat Cornea: The Role of Electric Currents. FASEB Journal, 19, 379-386. https://doi.org/10.1096/fj.04-2325com
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. https://doi.org/10.1016/S0140-6736(00)04046-0
Fiala, E.S., Sohn, O.S., Wang, C.X., et al. (2005) Induction of Preneoplastic Lung Lesions in Guinea Pigs by Cigarette Smoke Inhalation and their Exacerbation by High Dietary Levels of Vitamins C and E. Carcinogenesis, 26, 605-612. https://doi.org/10.1093/carcin/bgh341
Murthy, N.S. and Mathew, A. (2000) Risk Factors for Pre-Cancerous Lesions of the Cervix. European Journal of Cancer Prevention, 9, 5-14. https://doi.org/10.1097/00008469-200002000-00002
Molloy, R.M. and Sonnenberg, A. (1997) Relation between Gastric Cancer and Previous Peptic Ulcer Disease. Gut, 40, 247-252. https://doi.org/10.1136/gut.40.2.247
Sundaram, G.M., Quah, S. and Sampath, P. (2018) Cancer: The Dark Side of Wound Healing. The FEBS Journal, 285, 4516-4534. https://doi.org/10.1111/febs.14586
Schafer, M. and Werner, S. (2008) Cancer as an Overhealing Wound: An Old Hypothesis Revisited. Nature Reviews Molecular Cell Biology, 9, 628-638. https://doi.org/10.1038/nrm2455
Dvorak, H.F. (2015) Tumors: Wounds That Do Not Heal—Redux. Cancer Immunology Research, 3, 1-11. https://doi.org/10.1158/2326-6066.CIR-14-0209
Feng, Y., Santoriello, C., Mione, M., Hurlstone, A. and Martin, P. (2010) Live Imaging of Innate Immune Cell Sensing of Transformed Cells in Zebrafish Larvae: Parallels between Tumor Initiation and Wound Inflammation. PLOS Biology, 8, e1000562. https://doi.org/10.1371/journal.pbio.1000562
Gionzalez, H., Hagerling, C. and Werb, Z. (2018) Roles of the Immune System in Cancer: From Tumor Initiation to Metastatic Progression. Genes and Development, 32, 1267-1284. https://doi.org/10.1101/gad.314617.118
Jia, W., Li, H., Zhao, L., et al. (2008) Gut Microbiota: A Potential New Territory for Drug Targeting. Nature Reviews, 7, 123-129. https://doi.org/10.1038/nrd2505
Hanausek, M., Walaszek, Z. and Slaga, T.J. (2003) Detoxifying Cancer Causing Agents to Prevent Cancer. Integrative Cancer Therapies, 2, 139-144. https://doi.org/10.1177/1534735403002002005
Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E., Old, L.J. and Schreiber, R.D. (2001) IFNgamma and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity. Nature, 410, 1107-1111. https://doi.org/10.1038/35074122
Shankaran, V., Ikeda, H., Bruce, A.T., et al. (2018) Pillars Article: IFNgamma and Lymphocytes Prevent Primary Tumour Development and Shape Tumor Immunogenicity. The Journal of Immunology, 201, 827-831.
Dunn, G.P., Old, L.J. and Schreiber, R.D. (2004) The Immunobiology of Cancer Immunosurveillance and Immunoediting. Immunity, 21, 137-148. https://doi.org/10.1016/j.immuni.2004.07.017
Dunn, G.P., Koebel, C.M. and Schreiber, R.D. (2006) Interferons, Immunity and Cancer Immunoediting. Nature Reviews Immunology, 6, 836-848. https://doi.org/10.1038/nri1961
Miller, J.S. (2001) The Biology of Natural Killer Cells in Cancer, Infection, and Pregnancy. Experimental Hematology, 29, 1157-1168. https://doi.org/10.1016/S0301-472X(01)00696-8
Ghiringhelli, F., Menard, C., Martin, F. and Zitvogel, L. (2006) The Role of Regulatory T Cells in the Control of Natural Killer Cells: Relevance during Tumor Progression. Immunological Reviews, 214, 229-238. https://doi.org/10.1111/j.1600-065X.2006.00445.x
Honda, K. and Littman, D.R. (2016) The Microbiota in Adaptive Immune Homeostasis and Disease. Nature, 535, 75-84. https://doi.org/10.1038/nature18848
Belkaid, Y. and Harrison, O.J. (2017) Homeostatic Immunity and the Microbiota. Immunity, 46, 562-567. https://doi.org/10.1016/j.immuni.2017.04.008
Cholujova, D., Jakubikova, J. and Sedlak, J. (2009) Biobran-Augmented Maturation of Human Monocyte-Derived Dendritic Cells. Neoplasma, 56, 89-95. https://doi.org/10.4149/neo_2009_02_89
Romero, D. (2019) From New Directions in Immuno-Oncology. Nature Reviews Clinical Oncology, 16, 660. https://doi.org/10.1038/s41571-019-0280-7
Busch, W. (1868) Aus der Sitzung der medicinischen Section vom 13 November 1867. Berliner Klinische Wochenschrift, 5, 137.
Burnet, F.M. (1970) The Concept of Immunological Surveillance. Progress in Experimental Tumor Research, 13, 1-27. https://doi.org/10.1159/000386035
Akinleye, A. and Rasool, Z. (2019) Immune Checkpoint Inhibitors of PD-L1 as Cancer Therapeutics. Journal of Hematology & Oncology, 12, 92. https://doi.org/10.1186/s13045-019-0779-5
Bakacs, T., Mehrishi, J.N. and Moss, R.W. (2012) Ipilimumab (Yervoy) and the TGN1412 Catastrophe. Immunobiology, 217, 583-589. https://doi.org/10.1016/j.imbio.2011.07.005
Bakacs, T., Kristof, K., Mehrishi, J., et al. (2017) Autoimmune T-Cells Induced by Low Dose Immune Checkpoint Blockade Could Be a Powerful Therapeutic Tool in Cancer through Activation of Eliminative Inflammation and Immunity. Internal Medicine Review, 3, 1-8. https://doi.org/10.18103/imr.v3i4.408
Conklin, K.A. (2009) Dietary Antioxidants during Cancer Chemotherapy: Impact on Chemotherapeutic Effectiveness and Development of Side Effects. Nutrition and Cancer, 37, 1-18. https://doi.org/10.1207/S15327914NC3701_1
Tait, P., Morris, B. and To, T. (2014) Core Palliative Medicines-Meeting the Needs of Non-Complex Community Patients. Australian Family Physician, 43, 29-32.
International Association for Hospice and Palliative Care (IAHPC) (2013) World Health Organization (WHO) Essential Medicines in Palliative Care, Executive Summary. https://www.who.int/selection_medicines/committees/expert/19/applications/PalliativeCare_8_A_R.pdf
WA Cancer and Palliative Care Network, Essential Palliative Care Medication Lists for Community Pharmacists and General Practitioners, Government of Western Australia, Department of Health, 2011. https://ww2.health.wa.gov.au/~/media/Files/Corporate/general%20documents/Health%20Networks/WA%20Cancer%20and%20Palliative%20Care/Palliative%20care/Essential-Palliative-Care-Medication-Lists-for-Community-Pharmacists-and-General-Practitioners.pdf
Davies, A.M. Weinberg, U. and Palti, Y. (2013) Tumor Treating Fields: A New Frontier in Cancer Therapy. Annals of the New York Academy of Sciences, 1291, 86-95. https://doi.org/10.1111/nyas.12112
Chu, X.Y., Huang, W., Meng, L.W., et al. (2019) Improving Antitumor Outcomes for Palliative Intratumoral Injection Therapy through Lecithin-Chitosan Nanoparticles Loading Paclitaxel-Cholesterol Complex. International Journal of Nanomedicine, 14, 689-705. https://doi.org/10.2147/IJN.S188667
Liangruksa, M. (2011) Nanoscale Thermal Transport for Biological and Physical Applications. Dissertation, Virginia Polytechnic Institute and State University, Blacksburg.
Govorov, A.O. and Richardson, H.H. (2007) Generating Heat with Metal Nanoparticles. NanoToday, 2, 30-38. https://doi.org/10.1016/S1748-0132(07)70017-8
Gannon, C.J., Patra, C.R., Bhattacharya, R., et al. (2008) Intracellular Gold Nanoparticles Enhance Non-Invasive Radiofrequency Thermal Destruction of Human Gastrointestinal Cancer Cells. Journal of Nanobiotechnology, 6, 2. https://doi.org/10.1186/1477-3155-6-2
Szasz, A. (2015) Bioelectromagnetic Paradigm of Cancer Treatment Oncothermia. In: Rosch, P.J., Ed., Bioelectromagnetic and Subtle Energy Medicine, CRC Press, Taylor & Francis Group, Boca Raton, 323-336.
Raoof, M., Cisneros, B.T., Corr, S.J., et al. (2013) Tumor Selective Hyperthermia Induced by Short-Wave Capacitively-Coupled RF Electric-Fields. PLOS ONE, 8, e68506. https://doi.org/10.1371/journal.pone.0068506
Andocs, G., Rehman, M.U., Zhao, Q.L., Papp, E., Kondo, T. and Szasz, A. (2015) Nanoheating without Artificial Nanoparticles Part II. Experimental Support of the Nanoheating Concept of the Modulated Electro-Hyperthermia Method, Using U937 Cell Suspension Model. Biology and Medicine, 7, 1-9. https://doi.org/10.4172/0974-8369.1000247
Kirson, E.D., Dbaly, V., Tovarys, F., et al. (2007) Alternating Electric Fields Arrest Cell Proliferation, in Animal Tumor Models and Human Brain Tumors. Proceedings of the National Academy of Sciences of the United States of America, 104, 10152-10157. https://doi.org/10.1073/pnas.0702916104
Giladi, M., Munster, M., Schneiderman, R.S., et al. (2017) Tumor Treating Fields (Ttfields) Delay DNA Damage Repair Following Radiation Treatment of Glioma Cells. Radiation Oncology, 12, 206. https://doi.org/10.1186/s13014-017-0941-6
Stupp, R., Tailibert, S., Kanner, A., et al. (2017) Effect of Tumor-Treating Fields plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients with Glioblastoma: A Randomized Clinical Trial. JAMA, 318, 2306-2316. https://doi.org/10.1001/jama.2017.18718
Mun, E.J., Babiker, H.M., Weinber, U., et al. (2017) Tumor-Treating Fields: A Fourth Modality in Cancer Treatment. Clinical Cancer Research, 24, 266-275. https://doi.org/10.1158/1078-0432.CCR-17-1117
Szasz, O., Szigeti, G.P. and Szasz, A.M. (2017) Electrokinetics of Temperature for Development and Treatment of Effusions. Advances in Bioscience and Biotechnology, 8, 434-449. https://doi.org/10.4236/abb.2017.811032
Pang, C.L.K., Zhang, X., et al. (2017) Local Modulated Electro-Hyperthermia in Combination with Malignant Ascites: A Phase II Randomized Trial. Molecular and Clinical Oncology, 6, 723-732. https://doi.org/10.3892/mco.2017.1221
Vaupel, P.W. and Kelleher, D.K. (1996) Metabolic Status and Reaction to Heat of Normal and Tumor Tissue. In: Seegenschmiedt, M.H., Fessenden, P. and Vernon, C.C., Eds., Thermoradiotherapy and Thermochemotherapy: Biology, Physiology and Physics, Vol. 1, Springer Verlag, Berlin, 157-176. https://doi.org/10.1007/978-3-642-57858-8_8
Ferenczy, G.L. and Szasz, A. (2020) Ch. 3. Technical Challenges and Proposals in Oncological Hyperthermia. In: Szasz, A., Ed., Challenges and Solutions of Oncological Hyperthermia, Cambridge Scholars, Newcastle upon Tyne, 72-90. https://www.cambridgescholars.com/challenges-and-solutions-of-oncological-hyperthermia
Szentgyorgyi, A. (1968) Bioelectronics: A Study on Cellular Regulations, Defence and Cancer. Acad. Press, New York.
Szasz, O. (2013) Burden of Oncothermia—Why Is It Special? Conference Papers in Medicine, 2013, Article ID: 938689. http://www.hindawi.com/archive/2013/938689
Fiorentini, G. and Szasz, A. (2006) Hyperthermia Today: Electric Energy, a New Opportunity in Cancer Treatment. Journal of Cancer Research and Therapeutics, 2, 41-46. https://doi.org/10.4103/0973-1482.25848
Szasz, O. and Szasz, A. (2014) Oncothermia-Nano-Heating Paradigm. Journal of Cancer Science and Therapy, 6, 4. https://doi.org/10.4172/1948-5956.1000259
Szasz, A. (2013) Chapter 4. Electromagnetic Effects in Nanoscale Range. In: Shimizu, T. and Kondo, T., Eds., Cellular Response to Physical Stress and Therapeutic Applications, Nova Science Publishers, Inc., Hauppauge.
Vincze, G., Szigeti, G., Andocs, G. and Szasz, A. (2015) Nanoheating without Artificial Nanoparticles. Biology and Medicine, 7, 249.
Prasad, B., Kim, S., Cho, W., et al. (2018) Effect of Tumor Properties on Energy Absorption, Temperature Mapping, and Thermal Dose in 13.56-MHz Radiofrequency Hyperthermia. Journal of Thermal Biology, 74, 281-289. https://www.ncbi.nlm.nih.gov/pubmed/29801639
Lee, S.Y., Kim, J.H., et al. (2018) The Effect of Modulated Electro-Hyperthermia on Temperature and Blood Flow in Human Cervical Carcinoma. International Journal of Hyperthermia, 34, 953-960. https://doi.org/10.1080/02656736.2018.1423709
Szasz, O. (2013) Essentials of Oncothermia. Conference Papers in Medicine, 2013, Article ID: 159570. https://doi.org/10.1155/2013/159570
Wust, P., Ghadjar, P., Nadobny, J., et al. (2019) Physical Analysis of Temperature-Dependent Effects of Amplitude-Modulated Electromagnetic Hyperthermia. International Journal of Hypertension, 36, 1246-1254. https://doi.org/10.1080/02656736.2019.1692376
Szasz, A., Szasz, N. and Szasz, O. (2010) Oncothermia-Principles and Practices. Springer Science, Heidelberg. http://www.springer.com/gp/book/9789048194971
Szasz, O., Szasz, A.M., Minnaar, C. and Szasz, A. (2017) Heating Preciosity—Trends in Modern Oncological Hyperthermia. Open Journal of Biophysics, 7, 116-144. https://doi.org/10.4236/ojbiphy.2017.73010
Andocs, G., Renner, H., Balogh, L., Fonyad, L., Jakab, C. and Szasz, A. (2009) Strong Synergy of Heat and Modulated Electromagnetic Field in Tumor Cell Killing. Strahlentherapie und Onkologie, 185, 120-126. https://doi.org/10.1007/s00066-009-1903-1
Torok, Z., Crul, T., Maresca, B., et al. (2014) Plasma Membranes as Heat Stress Sensors: From Lipid-Controlled Molecular Switches to Therapeutic Applications. Biochimica et Biophysica Acta, 1838, 1594-1618. https://doi.org/10.1016/j.bbamem.2013.12.015
Staunton, J.R., Wirtz, D., Tlsty, T.D., et al. (2013) A Physical Sciences Network Characterization of Non-Tumorigenic and Metastatic Cells. Scientific Reports, 3, Article No. 1449. https://doi.org/10.1038/srep01449
Papp, E., Vancsik, T., Kiss, E. and Szasz, O. (2017) Energy Absorption by the Membrane Rafts in the Modulated Electro-Hyperthermia (mEHT). Open Journal of Biophysics, 7, 216-229. https://doi.org/10.4236/ojbiphy.2017.74016
Szasz, O. (2013) Renewing Oncological Hyperthermia-Oncothermia. Open Journal of Biophysics, 3, 245-252. https://doi.org/10.4236/ojbiphy.2013.34030
Szasz, O. (2019) Bioelectromagnetic Paradigm of Cancer Treatment-Modulated Electro-Hyperthermia (mEHT). OJBIPHY, 9, 98-109. https://doi.org/10.4236/ojbiphy.2019.92008
Meggyeshazi, N. andocs, G., Balogh, L., et al. (2014) DNA Fragmentation and Caspase-Independent Programmed Cell Death by Modulated Electrohyperthermia. Strahlentherapie und Onkologie, 190, 815-822. http://www.ncbi.nlm.nih.gov/pubmed/24562547
Yang, K.L., Huang, C.C., Chi, M.S., Chiang, H.C., Wang, Y.S. andocs, G., et al. (2016) In Vitro Comparison of Conventional Hyperthermia and Modulated Electro-Hyperthermia. Oncotarget, 7, 84082-84092. https://doi.org/10.18632/oncotarget.11444
Andocs, G., Meggyeshazi, N., Balogh, L., et al. (2014) Upregulation of Heat Shock Proteins and the Promotion of Damage-Associated Molecular Pattern Signals in a Colorectal Cancer Model by Modulated Electrohyperthermia. Cell Stress and Chaperones, 20, 37-46. http://www.ncbi.nlm.nih.gov/pubmed/24973890
Jeon, T.W., Yang, H., Lee, C.G., et al. (2016) Electro-Hyperthermia Up-Regulates Tumour Suppressor Septin 4 to Induce Apoptotic Cell Death in Hepatocellular Carcinoma. International Journal of Hypertension, 7, 1-9. https://doi.org/10.1080/02656736.2016.1186290
Meggyeshazi, N. (2015) Studies on Modulated Electrohyperthermia Induced Tumor Cell Death in a Colorectal Carcinoma Model. Thesis, Pathological Sciences Doctoral School, Semmelweis University, Budapest. http://repo.lib.semmelweis.hu/handle/123456789/3956
Andocs, G., Szasz, O. and Szasz, A. (2009) Oncothermia Treatment of Cancer: From the Laboratory to Clinic. Electromagnetic Biology and Medicine, 28, 148-165. https://doi.org/10.1080/15368370902724633
Fiorentini, G., Sarti, D., Casadei, V., et al. (2019) Modulated Electro-Hyperthermia as Palliative Treatment for Pancreas Cancer: A Retrospective Observational Study on 106 Patients. Integrative Cancer Therapies, 18, 1-8. https://doi.org/10.1177/1534735419878505
Szasz, A.M., Minnaar, C.A., Szentmartoni, G., et al. (2019) Review of the Clinical Evidences of Modulated Electro-Hyperthermia (Meht) Method: An Update for the Practicing Oncologist. Frontiers in Oncology, 9, Article No. 1012. https://doi.org/10.3389/fonc.2019.01012
Minnaar, C.A., Kotzen, J.A., Ayeni, O.A., et al. (2019) The Effect of Modulated Electro-Hyperthermia on Local Disease Control in HIV-Positive and -Negative Cervical Cancer Women in South Africa: Early Results from a Phase III Randomized Controlled Trial. PLOS ONE, 14, e0217894. https://doi.org/10.1371/journal.pone.0217894
Vincze, G., Szasz, O. and Szasz, A. (2015) Generalization of the Thermal Dose of Hyperthermia in Oncology. Open Journal of Biophysics, 5, 97-114. https://doi.org/10.4236/ojbiphy.2015.54009
Vincze, G. and Szasz, A. (2018) Similarities of Modulation by Temperature and by Electric Field. OJBIPHY, 8, 95-103. https://doi.org/10.4236/ojbiphy.2018.83008
Szasz, A., Vincze, G., Szasz, O. and Szasz, N. (2003) An Energy Analysis of Extracellular Hyperthermia. Magneto- and Electro-Biology, 22, 103-115. https://doi.org/10.1081/JBC-120024620
Hegyi, G., Szasz, O. and Szasz, A. (2013) Oncothermia: A New Paradigm and Promising Method in Cancer Therapies. Acupuncture & Electro-Therapeutics Research: The International Journal, 38, 161-197. https://doi.org/10.3727/036012913X13831832269243
Hegyi, G., Szigeti, G.P. and Szasz, A. (2013) Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy. Evidence-Based Complementary and Alternative Medicine, 2013, Article ID: 672873. https://doi.org/10.1155/2013/672873
Lee, S.Y., Szigeti, G.P. and Szasz, A.M. (2018) Oncological Hyperthermia: The Correct Dosing in Clinical Applications. International Journal of Oncology, 54, 627-643. https://doi.org/10.3892/ijo.2018.4645
Hager, D., Dziambor, H., Hoehmann, D., et al. (2002) Survival and Quality of Life of Patients with Advanced Pancreatic Cancer. Annual Meeting of the American Society of Clinical Oncology, Orlando, 18-21 May 2002, 2359.
Ou, J., Zhu, X., Chen, P., et al. (2020) A Randomized Phase II Trial of Best Supportive Care with or without Hyperthermia and Vitamin C for Heavily Pretreated, Advanced, Refractory Non-Small-Cell Lung Cancer. Journal of Advanced Research, 24, 175-182. https://www.ncbi.nlm.nih.gov/pubmed/32368355
Prasad, B., Kim, S., Cho, W., et al. (2019) Quantitative Estimation of the Equivalent Radiation Dose Escalation Using Radiofrequency Hyperthermia in Mouse Xenograft Models of Human Lung Cancer. Scientific Reports, 9, Article No. 3942. https://doi.org/10.1038/s41598-019-40595-6
Vancsik, T., Forika, G., Balogh, A., et al. (2019) Modulated Electro-Hyperthermia Induced P53 Driven Apoptosis and Cell Cycle Arrest Additively Support Doxorubicin Chemotherapy of Colorectal Cancer in Vitro. Cancer Medicine, 8, 4292-4303. https://doi.org/10.1002/cam4.2330
Tsang, Y.W., Chi, K.H., et al. (2019) Modulated Electro-Hyperthermia-Enhanced Liposomal Drug Uptake by Cancer Cells. International Journal of Nanomedicine, 14, 1269-1579. https://doi.org/10.2147/IJN.S188791
Roussakow, S. (2013) The History of Hyperthermia Rise and Decline. Conference Papers in Medicine, 2013, Article ID: 201671. http://www.hindawi.com/journals/cpis/2013/428027
Szasz, A., Szasz, N. and Szasz, O. (2013) Local Hyperthermia in Oncology—to Choose or Not to Choose? In: Huilgol, N., Ed., Hyperthermia, InTech, London, 1-82. https://doi.org/10.5772/52208
Vernon, C.C., Hand, J.W., Field, S.B., et al. (1996) Radiotherapy with or without Hyperthermia in the Treatment of Superficial Localized Breast Cancer: Results from Five Randomized Controlled Trials. International Journal of Radiation Oncology, Biology, Physics, 35, 731-744. https://doi.org/10.1016/0360-3016(96)00154-X
Sherar, M., Liu, F.F., Pintilie, M., et al. (1997) Relationship between Thermal Dose and Outcome in Thermoradiotherapy Treatments for Superficial Recurrences of Breast Cancer: Data from a Phase III Trial. International Journal of Radiation Oncology, Biology, Physics, 39, 371-380. https://doi.org/10.1016/S0360-3016(97)00333-7
Zolciak-Siwinska, A., Piotrokowicz, N., Jonska-Gmyre, J., et al. (2013) HDR Brachytherapy Combined with Interstitial Hyperthermia in Locally Advanced Cervical Cancer Patients Initially Treated with Concomitant Radiochemotherapy—A Phase III Study. Radiotherapy and Oncology, 109, 194-199. https://doi.org/10.1016/j.radonc.2013.04.011
Kay, C.S., Choi, I.B., Jang, J.Y., Choi, B.O., Kim, I.A., Shinn, K.S., et al. (1996) Thermoradiotherapy in the Treatment of Locally Advanced Nonsmall Cell Lung Cancer. The Journal of the Korean Society for Therapeutic Radiology and Oncology, 14, 115-122. https://doi.org/10.1016/0169-5002(96)85955-1
Jones, E.L., Oleson, J.R., Prosnith, L.R., et al. (2007) Randomized Trial of Hyperthermia and Radiation for Superficial Tumours. Journal of Clinical Oncology, 23, 3079-3085. https://doi.org/10.1200/JCO.2005.05.520
Mitsumori, M., Zhi-Fan, Z., Oliynychenko, P., et al. (2007) Regional Hyperthermia Combined with Radiotherapy for Locally Advanced Non-Small Cell Lung Cancers: A Multi-Institutional Prospective Randomized Trial of the International Atomic Energy Agency. International Journal of Clinical Oncology, 12, 192-198. https://doi.org/10.1007/s10147-006-0647-5
Barker, A.T., Jaffe, L.F. and Vanable, J.W. (1982) The Glabrous Epidermis of Cavies Contains a Powerful Battery. American Journal of Physiology, 242, R358-R366. https://doi.org/10.1152/ajpregu.1982.242.3.R358
Rosch, P.J. and Markov, M.S. (2004) Bioelectromagnetic Medicine. Marcell Decker Inc., New York. https://doi.org/10.3109/9780203021651
Samuelsson, L., Jonsson, L. and Stahl, E. (1983) Percutaneous Treatment of Pulmonary Tumors by Electrolysis. Radiologie, 23, 284-287. https://doi.org/10.1016/0011-2275(83)90154-6
Song, B., Zhao, M., Forrester, J., et al. (2004) Nerve Regeneration and Wound Healing Are Stimulated and Directed by an Endogenous Electrical Field in Vivo. Journal of Cell Science, 117, 4681-4690. https://doi.org/10.1242/jcs.01341
Carbon, M., Wübbeler, G., Mackert, B.M., et al. (2004) Non-Invasive Magnetic Detection of Human Injury Currents. Clinical Neurophysiology, 115, 1027-1032. https://doi.org/10.1016/j.clinph.2003.12.035
Reid, B., Nuccitelli, R. and Zhao, M. (2007) Non-Invasive Measurement of Bioelectric Currents with a Vibrating Probe. Nature Protocols, 2, 661-669. https://doi.org/10.1038/nprot.2007.91
Mackert, B.M., Mackert, J., Wübbeler, G., et al. (1999) Magnetometry of Injury Currents from Human Nerve and Muscle Specimens Using Superconducting Quantum Interferences Devices. Neuroscience Letters, 262, 163-166. https://doi.org/10.1016/S0304-3940(99)00067-1
Zhao, M., Forrester, J.V. and McCaig, C.D. (1999) A Small, Physiological Electric Field Orients Cell Division. Proceedings of the National Academy of Sciences of the United States of America, 96, 4942-4946. https://doi.org/10.1073/pnas.96.9.4942
Song, B., Zhao, M., Forrester, J.V., et al. (2002) Electrical Cues Regulate the Orientation and Frequency of Cell Division and the Rate of Wound Healing in Vivo. PNAS, 99, 13577-13582. https://doi.org/10.1073/pnas.202235299
Zhao, M. (2009) Electrical Fields in Wound Healing—An Overriding Signal That Directs Cell Migration. Seminars in Cell & Developmental Biology, 20, 674-682. https://doi.org/10.1016/j.semcdb.2008.12.009
Huttenlocher, A. (2007) Wound Healing with Electric Potential. NEJM, 356, 304-305. https://doi.org/10.1056/NEJMcibr066496
Becker, R.O. and Selden, G. (1985) The Body Electric. Morrow, New York.
Becker, R.O. (1990) Cross Currents. Jeremy P Tarcher Inc., Los Angeles.
McCaig, C.D., Rajnicek, A.M., Song, B., et al. (2005) Controlling Cell Behaviour Electrically: Current Views and Future Potential. Physiological Reviews, 85, 943-978. https://doi.org/10.1152/physrev.00020.2004
Rosenberg, S.M. and Queitsch, C. (2014) Combating Evolution to Fight Disease. Science, 343, 1088-1089. https://doi.org/10.1126/science.1247472
Galluzzi, L., Zitvogel, L. and Kroemer, G. (2016) Immunological Mechanisms underneath the Efficacy of Cancer Therapy. Cancer Immunology Research, 4, 895-902. https://doi.org/10.1158/2326-6066.CIR-16-0197
Waldhauer, I. and Steinle, A. (2008) NK Cells and Cancer Immunosurveillance. Oncogene, 27, 5932-5943. https://doi.org/10.1038/onc.2008.267
Zamai, L., Ponti, C., Mirandola, P., et al. (2007) NK Cells and Cancer. The Journal of Immunology, 178, 4011-4016. https://doi.org/10.4049/jimmunol.178.7.4011
Hu, W., Wang, G., Huang, D., et al. (2019) Cancer Immunotherapy Based on Natural Cell Killer Cells: Current Progress and New Opportunities. Frontiers in Immunology, 10, Article No. 1205. https://doi.org/10.3389/fimmu.2019.01205
Bassani, B., Baci, D. and Gallazzi, M. (2019) Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects. Cancers, 11, 461. https://doi.org/10.3390/cancers11040461
Betten, A., Dahlgren, C., Mellqvist, U.H., et al. (2004) Oxygen Radical-Induced Natural Killer Cell Dysfunction: Role of Myeloperosicase and Regulation by Serotonin. Journal of Leukocyte Biology, 75, 1111-1115. https://doi.org/10.1189/jlb.1103595
Sag, D., Ayyildiz, Z.O., Gunalp, S., et al. (2019) The Role of TRAIL/Drs in the Modulation of Immune Cells and Responses. Cancers, 11, 1469. https://doi.org/10.3390/cancers11101469
Wajant, H. (2019) Molecular Mode of Action of TRAIL Receptor Agonists Common Principles and Their Translational Exploitation. Cancers, 11, 954. https://doi.org/10.3390/cancers11070954
Mifsud, E.J., Tan, A.C.L. and Jacks, D.C. (2014) TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents against Infectious Disease. Frontiers in Immunology, 5, Article No. 79. https://doi.org/10.3389/fimmu.2014.00079
Meggyeshazi, N. andocs, G., et al. (2013) Early Changes in mRNA and Protein Expression Related to Cancer Treatment by Modulated Electro-Hyperthermia. Conference Papers in Medicine, 2013, Article ID: 249563. http://www.hindawi.com/archive/2013/249563
Masuda, Y., Nawa, D. and Nakayama, Y. (2015) Soluble b-Glucan from Grifola frondosa Induces Tumor Regression in Synergy with TLR9 Agonist via Dendritic Cell-Mediated Immunity. Journal of Leukocyte Biology, 98, 1015-1025. https://doi.org/10.1189/jlb.1A0814-415RR
Showalter, A., Limaye, A. and Oyer, J.L. (2017) Cytokines in Immunogenic Cell Death: Applications for Cancer Immonotherapy. Cytokine, 97, 123-132. https://doi.org/10.1016/j.cyto.2017.05.024
Krysko, O., Aaes, T.L. and Bachert, C. (2013) Many Faces of DAMPs in Cancer Therapy. Cell Death and Disease, 4, e631. https://doi.org/10.1038/cddis.2013.156
Hernandez, C., Huebener, P. and Schwabe, R.F. (2016) Damage Associated Molecular Patterns in Cancer: A Double-Edged Sword. Oncogene, 35, 5931-5941. https://doi.org/10.1038/onc.2016.104
Repasky, E.A. and Evans, S.S. (2013) Temperature Matters! And Why It Should Matter to Tumor Immunologists. Cancer Immunology Research, 1, 210-216. https://doi.org/10.1158/2326-6066.CIR-13-0118
Dieing, A., Ashlers, O. and Hildebrandt, B. (2007) The Effect of Induced Hyperthermia on the Immune System. Progress in Brain Research, 162, 137-152. https://doi.org/10.1016/S0079-6123(06)62008-6
Sulyok, I., Fleishmann, E. and Stift, A. (2012) Effect of Preoperative Fever-Range Whole-Body Hyperthermia on Immunological Markers in Patients Undergoing Colorectal Cancer Surgery. British Journal of Anaesthesia, 109, 754-761. https://doi.org/10.1093/bja/aes248
Shen, R.N., Lu, L., Young, P., Shidnia, H., Hornback, N.B. and Broxmeyer, H.E. (1994) Influence of Elevated Temperature on Natural Killer Cell Activity, Lymphokine-Activated Killer Cell Activity and Lecitin-Dependent Cytotoxicity of Human Umbilical Cord Blood and Adult Blood Cell. International Journal of Radiation Oncology, Biology, Physics, 29, 821-826. https://doi.org/10.1016/0360-3016(94)90571-1
Hietanen, T., Kapanen, M. and Kellokumpu-Lehtinen, P.L. (2016) Restoring Natural Killer Cell Cytotoxicity after Hyperthermia Alone or Combined with Radiotherapy. Anticancer Research, 36, 555-564.
Beachy. S.H. and Repasky, E.A. (2011) Toward Establishment of Temperature Thresholds for Immunological Impact of Heat Exposure in Humans. International Journal of Hyperthermia, 27, 344-352. https://doi.org/10.3109/02656736.2011.562873
Staunton, J.R., et al. (2008) The Physical Sciences-Oncology Centers Network, a Physical Sciences Network Characterization of Non-Tumorigenic and Metastatic Cells. Scientific Reports, 3, Article No. 1449.
Szasz, A. (2019) Thermal and Nonthermal Effects of Radiofrequency on Living State and Applications as an Adjuvant with Radiation Therapy. Journal of Radiation and Cancer Research, 10, 1-17. https://doi.org/10.4103/jrcr.jrcr_25_18
Vincze, G. and Szasz, A. (2015) Effect of Cellular Membrane Resistivity Inhomogeneity on the Thermal Noise-Limit. Journal of Advances in Physics, 11, 3170-3183. https://doi.org/10.24297/jap.v11i3.6859
Ye, L., Zhang, T. and Kang, Z. (2019) Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer. Frontiers in Immunology, 10, Article No. 2368. https://doi.org/10.3389/fimmu.2019.02368
Mole, R.H. (1953) Whole Body Irradiation-Radiology or Medicine? British Journal of Radiology, 26, 234-241. https://doi.org/10.1259/0007-1285-26-305-234
Cavanagh, W. (2009) The Abscopal Effect and the Prospect of Using Cancer against Itself, Prostate Cancer Research Institute. PCRI Insights, Vol. 12.1.
Wersäll, P.J., Blomgren, H., Pisa, P., Lax, I., Kälkner, K.M. and Svedman, C. (2006) Regression of Non-Irradiated Metastases after Extracranial Stereotactic Radiotherapy in Metastatic Renal Cell Carcinoma. Acta Oncologica, 45, 493-497. https://doi.org/10.1080/02841860600604611
Trott, K.R. (2001) Non-Targeted Radiation Effects in Radiotherapy-Roles of Radiation-Induced Genomic Instability and of the Bystander Effect in Cancer Cure by Radiotherapy. Acta Oncologica, 40, 976-980. https://doi.org/10.1080/02841860152708260
Hartford, A., Gohongi, T., Fukumura, D. and Jain, R. (2000) Irradiation of a Primary Tumor, Unlike Surgical Removal, Enhances Angiogenesis Suppression at a Distal Site: Potential Role of Host-Tumor Interaction. Cancer Research, 60, 2128-2131.
Uchida, A., Mizutani, Y., Nagamuta, M. and Ikenaga, M. (1989) Elevation of Sensitivity of Tumor Cells and Lytic Function of NK Cells. Immunopharmacology and Immunotoxicology, 11, 507-519. https://doi.org/10.3109/08923978909005381
Tubin, S. and Raunik, W. (2017) Hunting for Abscopal and Bystander Effects: Clinical Exploitation of Non-Targeted Effects Induced by Partial High-Single-Dose Irradiation of the Hypoxic Tumour Segment in Oligometastatic Patients. Acta Oncologica, 56, 1333-1339. https://doi.org/10.1080/0284186X.2017.1346385
Pouget, J.P., Georgakilas, A.G. and Ravanat, J.L. (2018) Targeted and Off-Target (Bystander and Abscopal) Effects of Radiation Therapy: Redox Mechanism and Risk/Benefit Analysis. Antioxidant & Redox Signaling, 29, 1447-1487. https://doi.org/10.1089/ars.2017.7267
Wang, R., Zhou, T., Liu, W. and Zuo, L. (2018) Molecular Mechanism of Bystander Effects and Related Abscopal/Cohort Effects in Cancer Therapy. Oncotarget, 9, 18637-18647. https://doi.org/10.18632/oncotarget.24746
Demaria, S., Ng, B., Devitt, M.L., Babb, J.S., Kawashima, N., Liebes, L. and Formenti, S.C. (2004) Ionizing Radiation Inhibition of Distant Untreated Tumors (Abscopal Effect) Is Immune Mediated. International Journal of Radiation Oncology, Biology, Physics, 58, 862-870. https://doi.org/10.1016/j.ijrobp.2003.09.012
Kaminski, J.M., Shinohara, E., Summers, J.B., Niermann, K.J., Morimoto, A. and Brousal, J. (2005) The Controversial Abscopal Effect. Cancer Treatment Reviews, 31, 159-172. https://doi.org/10.1016/j.ctrv.2005.03.004
Porter, D.L., Levine, B.L., Kalos, M., Bagg, A. and June, C.H. (2011) Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia. The New England Journal of Medicine, 365, 725-733. https://doi.org/10.1056/NEJMoa1103849
Nobler, M. (1969) The Abscopal Effect in Malignant Lymphoma and Its Relationship Tolymphocyte Circulation. Radiology, 93, 410-412. https://doi.org/10.1148/93.2.410
Antoniades, J., Brady, L. and Lightfoot, D. (1977) Lymphangiographic Demonstration of the Abscopal Effect in Patients with Malignant Lymphomas. International Journal of Radiation Oncology, Biology, Physics, 2, 141-147. https://doi.org/10.1016/0360-3016(77)90020-7
Formenti, S.C. and Demaria, S. (2009) Systemic Effects of Local Therapy. The Lancet Oncology, 10, 718-726. https://doi.org/10.1016/S1470-2045(09)70082-8
Rees, G.J. (1981) Abscopal Regression in Lymphoma: A Mechanism in Common with Total Body Irradiation? Clinical Radiology, 32, 475-480. https://doi.org/10.1016/S0009-9260(81)80310-8
Ehlers, G. and Fridman, M. (1973) Abscopal Effect of Radiation in Papillary Adenocarcinoma. The British Journal of Radiology, 46, 220-222. https://doi.org/10.1259/0007-1285-46-543-220
Kingsley, D. (1975) An Interesting Case of Possible Abscopal Effect in Malignant Melanoma. The British Journal of Radiology, 48, 863-866. https://doi.org/10.1259/0007-1285-48-574-863
Rees, G. and Ross, C. (1983) Abscopal Regression Following Radiotherapy for Adenocarcinoma. The British Journal of Radiology, 56, 63-66. https://doi.org/10.1259/0007-1285-56-661-63
Rees, G.J.G., Ross, C.M.D. and Path, F.R.C. (1983) Abscopal Regression Following Radiotherapy for Adenocarcinoma. British Journal of Radiology, 56, 63-66. https://doi.org/10.1259/0007-1285-56-661-63
Lakshmanagowda, P.B., Viswanath, L., Thimmaiah, N., Dasappa, L., Supe, S.S. and Kallur, P. (2009) Abscopal Effect in a Patient with Chronic Lymphocytic Leukemia during Radiation Therapy: A Case Report. Cases Journal, 2, 204. https://www.casesjournal.com/content/2/1/204
Sham, R. (1995) The Abscopal Effect and Chronic Lymphocytic Leukemia. The American Journal of Medicine, 98, 307-308. https://doi.org/10.1016/S0002-9343(99)80380-5
Smith, J.A. and Herr, H.W. (1979) Spontaneous Regression of Pulmonary Metastases from Transitional Cell Carcinoma. Cancer, 46, 1499-1502. https://doi.org/10.1002/1097-0142(19800915)46:6 3.0.CO;2-G
Van der Meeren, A., Monti, P., Vandamme, M., Squiban, C., Wysocki, J. and Griffiths, N. (2005) Abdominal Radiation Exposure Elicits Inflammatory Responses and Abscopal Effects in the Lungs of Mice. Radiation Research, 163, 144-152. https://doi.org/10.1667/RR3293
Ohba, K., Omagari, K., Nakamura, T., Ikuno, N., Saeki, S., Matsuo, I., Kinoshita, H., Masuda, J., Hazama, H., Sakamoto, I. and Kohno, S. (1998) Abscopal Regression of Hepatocellular Carcinoma after Radiotherapy for Bone Metastasis. Gut, 43, 575-577. https://doi.org/10.1136/gut.43.4.575
Nakanishi, M., Chuma, M., Hige, S. and Asaka, M. (2008) Abscopal Effect on Hepatocellular Carcinoma. The American Journal of Gastroenterology, 103, 1320-1321. https://doi.org/10.1111/j.1572-0241.2007.01782_13.x
Menon, H., Chen, D. and Ramapriyan, R. (2019) Influence of Low-Dose Radiation on Abscopal Responses in Patients Receiving High-Dose Radiation and Immunotherapy. Journal for ImmunoTherapy of Cancer, 7, 237. https://doi.org/10.1186/s40425-019-0718-6
Zahidunnabi, M., et al. (2009) Fractionated But Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect When Combined with Anti-CTLA-4 Antibody. Clinical Cancer Research, 15, 5379-5388. https://doi.org/10.1158/1078-0432.CCR-09-0265
Liu, Y., Dong, Y. and Kong, L. (2018) Abscopal Effect of Radiotherapy Combined with Immune Checkpoint Inhibitors. Journal of Hematology & Oncology, 11, 104. https://doi.org/10.1186/s13045-018-0647-8
Dagoglu, N., Karaman, S., Caglar, H.B., et al. (2019) Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases. Cureus, 11, e4103. https://doi.org/10.7759/cureus.4103
Lauber, K. and Dunn, L. (2019) Immunotherapy Mythbusters in Head and Neck Cancer: The Abscopal Effect and Pseudoprogression. American Society of Clinical Oncology Educational Book, 39, 352-363. https://doi.org/10.1200/EDBK_238339
Liu, J. and Mackley, H.B. (2019) Combining Immunotherapy with Radiation Therapy to Induce the Abscopal Response: What Clinical and Treatment Variables Matter? Applied Radiation Oncology, 8, 13-19.
Yilmaz, M.T., Elmali, A. and Yazici, G. (2019) Abscopal Effect: From Myth to Reality from Radiation Oncologists’ Perspective. Cureus, 11, e3860. https://doi.org/10.7759/cureus.3860
Seidi, K., Zarghami, N. and Jahanban-Esfahlan, R. (2013) Proposed Approach for Revealing Unknown Mediators of Abscopal. Journal of Medical Hypotheses and Ideas, 7, 43-49. https://doi.org/10.1016/j.jmhi.2013.03.001
Keisari, Y. (2013) Tumor Ablation, Effects on Systemic and Local Anti-Tumor Immunity and on Other Tumor-Microenvironment. Springer, Berlin. https://doi.org/10.1007/978-94-007-4694-7
Wang, H., Zhang, L. and Shi, Y. (2013) Abscopal Antitumor Immune Effects of Magnet-Mediated Hyperthermia at a High Therapeutic Temperature on Walker-256 Carcinosarcomas in Rats. Oncology Letters, 7, 764-770. https://doi.org/10.3892/ol.2014.1803
Persson, B.R.R., Koch, C., Graftsröm, G., et al. (2004) Abscopal Regression of Subcutaneously Implanted N29 Rat Glioma after Treatment of the Contra-Lateral Tumours with Pulsed Electric Fields (PEF) or Radiation Therapy (RT) and Their Combinations (PEF+RT). Cancer Therapy, 2, 533-548. https://doi.org/10.1177/153303460300200512
Falk, R.E., Moffa, F.L. and Lawler, M. (1985) Combination Therapy for Resectable and Unresectable Adenocarcinoma of the Pancreas. Cancer, 57, 685-688. https://doi.org/10.1002/1097-0142(19860201)57:3 3.0.CO;2-X
Oei, A.L., Korangath, P. and Mulka, K. (2019) Enhancing the Abscopal Effect of Radiation and Immune Checkpoint Inhibitor Therapies with Magnetic Nanoparticle Hyperthermia in a Model of Metastatic Breast Cancer. International Journal of Hyperthermia, 36, 47-63. https://doi.org/10.1080/02656736.2019.1685686
Dank, M., Meggyeshazi, N., Szigeti, G. and Andocs, G. (2016) Immune Effects by Selective Heating of Membrane Rafts of Cancer-Cells. Journal of Clinical Oncology, 34, e14571. https://meetinglibrary.asco.org/record/124231/abstract
Ngwa, W., Irabor, O.C. and Schoenfield, J.D. (2018) Using Immunotherapy to Boost the Abscopal. Nature Reviews Cancer, 18, 313-322. https://doi.org/10.1038/nrc.2018.6
Honkoop, A.H., Luykx-de, Bakker, S.A., Hoekman, K., Meyer, S., Meyer, O.W., van Groeningen, C.J., van Diest, P.J., Boven, E., van der Wall, E., Giaccone, G., Wagstaff, J. and Pinedo, H.M. (1999) Prolonged Neoadjuvant Chemotherapy with GM-CSF in Locally Advanced Breast Cancer. Oncologist, 4, 106-111. https://doi.org/10.1634/theoncologist.4-2-106
Spitler, L.E., Weber, R.W., Allen, R.E., Meyer, J., Cruickshank, S., Garbe, E., Lin, H.Y. and Soong, S.J. (2009) Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF, Ssargramostim) Administered for 3 Years as Adjuvant Therapy of Stages II(T4), III, and IV Melanoma. Journal of Immunotherapy, 32, 632-637. https://doi.org/10.1097/CJI.0b013e3181a7d60d
Leary, R., Gardner, R.B. and Mockbee, C. (2019) Boosting Abscopal Response to Radiotherapy with Sargramostim: A Review of Data and Ongoing Studies. Cureus, 11, e4276. https://doi.org/10.7759/cureus.4276
Fiorentini, G., Yoon, S.M., Yan, O. andocs, G., Baronzio, G.F., Laurent, S., Balogh, L. and Szasz, A. (2013) Abscopal Effect: New Perspectives in Oncothermia. Oncothermia Journal, 7, 279-281. https://oncotherm.com/sites/oncotherm/files/2017-07/Abscopal_effect_new_perspectives_in_Oncothermia_T.pdf
Andocs, G., Meggyeshazi, N., Okamoto, Y., Balogh, L. and Szasz, O. (2013) Bystander Effect of Oncothermia. Conference Papers in Medicine, 2013, Article ID: 953482. https://doi.org/10.1155/2013/953482
Derer, A., Deloch, L. and Rubner, Y. (2015)-Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses-pre-Clinical Evidence and Ongoing Clinical Applications. Frontiers in Immunology, 6, Article No. 505. https://doi.org/10.3389/fimmu.2015.00505
Vancsik, T., Kovago, C., Kiss, E., et al. (2018) Modulated Electro-Hyperthermia Induced Loco-Regional and Systemic Tumor Destruction in Colorectal Cancer Allografts. Journal of Cancer, 9, 41-53. https://doi.org/10.7150/jca.21520
Qin, W., Akutsu, Y. andocs, G., et al. (2014) Modulated Electro-Hyperthermia Enhances Dendritic Cell Therapy through an Abscopal Effect in Mice. Oncology Reports, 32, 2373-2379. https://doi.org/10.3892/or.2014.3500
Tsang, Y.W., Huang, C.C., Yang, K.L., et al. (2015) Improving Immunological Tumor Microenvironment Using Electro-Hyperthermia Followed by Dendritic Cell Immunotherapy. BMC Cancer, 15, Article No. 708. https://doi.org/10.1186/s12885-015-1690-2
Andocs, G., Szasz, A., Szasz, O. and Iluri, N. (2016) Tumor Vaccination Patent. EP2780024B1. US20150217099A1. https://patents.google.com/patent/EP2780024B1/en
Iyikesici, M.S., Slocum, A.K., Slocum, A., et al. (2017) Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer. Cureus, 9, e1445. https://doi.org/10.7759/cureus.1445
Schirrmacher, V. (2015) Oncolytic Newcastle Disease Virus as a Prospective Anti-Cancer Therapy. A Biologic Agent with Potential to Break Therapy Resistance. Expert Opinion on Biological Therapy, 15, 1757-1771. https://doi.org/10.1517/14712598.2015.1088000
Schirrmacher, V., Lorenzen, D., Van Gool, S.W., et al. (2017) A New Strategy of Cancer Immunotherapy Combining Hyperthermia/Oncolytic Virus Pretreatment with Specific Autologous Anti-Tumor Vaccination—A Review. Austin Oncology Case Reports, 2, 1006. https://doi.org/10.26420/austinoncolcaserep.1006.2017
Schirrmacher, V., Stücker, W., Lulei, M., et al. (2015) Long-Term Survival of a Breast Cancer Patient with Extensive Liver Metastases upon Immune and Virotherapy: A Case Report. Immunotherapy, 7, 855-860. https://doi.org/10.2217/imt.15.48
Schirrmacher, V., Bihari, A.S., Stücker, W., et al. (2014) Long-Term Remission of Prostate Cancer with Extensive Bone Metastases upon Immuno- and Virotherapy: A Case Report. Oncology Letters, 8, 2403-2406. https://doi.org/10.3892/ol.2014.2588
Van Gool, S.W., Makalowski, J., Feyen, O., Prix, L., Schirrmacher, V. and Stuecker, W. (2018) The Induction of Immunogenic Cell Death (ICD) during Maintenance Chemotherapy and Subsequent Multimodal Immunotherapy for Glioblastoma (GBM). Austin Oncology Case Reports, 3, 1010.
Ben-Jacob, E. (2013) Engineering Trojan-Horse Bacteria to Fight Cancer. Inside Blood, 122, 705-706. https://doi.org/10.1182/blood-2013-06-508481
Kleef, R., Kekic, S. and Ludwig, N. (2012) Successful Treatment of Advanced Ovarian Cancer with Thermochemotherapy and Adjuvant Immune Therapy. Case Reports in Oncology, 5, 212-215. https://doi.org/10.1159/000338617
Minnaar, C.A., Szigeti, G.P., et al. (2018) Modulated Electro-Hyperthermia as a Monotherapy: A Potential for Further Research? 36th ICHS Conference, Budapest, 28-29 September 2018.
Roussakow, S. (2017) Clinical and Economic Evaluation of Modulated Electrohyperthermia Concurrent to Dose-Dense Temozolomide 21/28 Days Regimen in the Treatment of Recurrent Glioblastoma: A Retrospective Analysis of a Two-Centre German Cohort Trial with Systematic Comparison and Effect-to-Treatment Analysis. BMJ Open, 7, e017387. http://bmjopen.bmj.com/content/bmjopen/7/11/e017387.full.pdf
Hager, E.D., Sahinbas, H., Groenemeyer, D.H., et al. (2008) Prospective Phase II Trial for Recurrent High-Grade Malignant Gliomas with Capacitive Coupled Low Radiofrequency (LRF) Deep Hyperthermia. Journal of Clinical Oncology, (Post-Meeting Edition), 26, 2047. https://doi.org/10.1200/jco.2008.26.15_suppl.2047
Sahinbas, H., Groenemeyer, D.H.W., Boecher, E. and Szasz, A. (2007) Retrospective Clinical Study of Adjuvant Electro-Hyperthermia Treatment for Advanced Brain-Gliomas. Deutsche Zeitschrift fuer Onkologie, 39, 154-160. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-2007-986020
Fiorentini, G., Sarti, D., Milandri, C., et al. (2018) Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study. Integrative Cancer Therapies, 18, 1534735418812691. https://www.ncbi.nlm.nih.gov/pubmed/30580645
Szasz, A. (2014) Current Status of Oncothermia Therapy for Lung Cancer. The Korean Journal of Thoracic and Cardiovascular Surgery, 47, 77-93. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000888
Lee, D.J., Haam, S.J., Kim, T.H., et al. (2013) Oncothermia with Chemotherapy in the Patients with Small Cell Lung Cancer. Conference Papers in Medicine, 2013, Article ID: 910363. http://www.hindawi.com/archive/2013/910363
Lee, S.Y., Lee, N.R., Cho, D.H., et al. (2017) Treatment Outcome Analysis of Chemotherapy Combined with Modulated Electro-Hyperthermia Compared with Chemotherapy Alone for Recurrent Cervical Cancer, Following Irradiation. Oncology Letters, 14, 73-78. http://www.spandidos-publications.com/10.3892/ol.2017.6117
Jeung, T.S., Ma, S.Y., Yu, J., et al. (2013) Cases that Respond to Oncothermia Monotherapy. Conference Papers in Medicine, 2013, Article ID: 392480. https://www.hindawi.com/journals/cpis/2013/392480 https://doi.org/10.1155/2013/392480
Nixon, R. (1971) National Cancer Act. The Time of Declaration. https://www.cancer.gov/about-nci/overview/history/national-cancer-act-1971
Yeung, K.S., Gubili, J. and Mao, J.J. (2018) Herb-Drug Interactions in Cancer Care. Oncology (Williston Park), 32, 516-520.
McEwen, B.S. (2006) Protective and Damaging Effects of Stress Mediators: Central Role of the Brain. Dialogus in Clinical Neuroscience, 8, 367-381. https://doi.org/10.31887/DCNS.2006.8.4/bmcewen
Dhabhar, F.S. (2019) The Power of Positive Stress—A Complementary Commentary. Stress, 22, 526-529. https://doi.org/10.1080/10253890.2019.1634049
Smith, S.M. and Val, W.W. (2006) The Role of Hypothalamic-Pituitary-Adrenal Axis in Neuroendocrine Responses to Stress. Dialogus in Clinical Neuroscience, 8, 383-395. https://doi.org/10.31887/DCNS.2006.8.4/ssmith
Klimes-Dougan, B., Chong, L.S., Samikoglu, A., Thai, M., et al. (2020) Transcendental Meditation and Hypothalamic-Pituitary-Adrenalaxis Functioning: A Pilot, Randomizd Controlled Trial with Young Adults. Stress, 23, 105-115. https://doi.org/10.1080/10253890.2019.1656714
Yamanaka, Y., Motoshima, H. and Uchida, K. (2019) Hypothalamic-Pituitary-Adrenal Axis Differentially Responses to Morning and Evening Psychological Stress in Healthy Subjects. Neuropsychopharmacology Reports, 39, 41-47. https://doi.org/10.1002/npr2.12042
Storm, F.K. (1993) What Happened to Hyperthermia and What Is Its Current Status in Cancer Treatment? Journal of Surgical Oncology, 53, 141-143. https://doi.org/10.1002/jso.2930530302
Nielsen, O.S., Horsman, M. and Overgaard, J. (2001) A Future of Hyperthermia in Cancer Treatment? (Editorial Comment). European Journal of Cancer, 37, 1587-1589. https://doi.org/10.1016/S0959-8049(01)00193-9
van der Zee, J., Vujaskovic, Z., Kondo, M., et al. (2008) The Kadota Fund International Forum 2004-Clinical Group Consensus. International Journal of Hyperthermia, 24, 111-122. https://doi.org/10.1080/02656730801895058
Wust, P. (2019) Physical Rationale about Amplitude Modulated Radiofrequency Hyperthermia. ESHO-2019, Warsaw, 22-24 May 2019.
Wust, P. (2019) Advantages of Amplitude Modulation in the Radiofrequency Hyperthermia. IX. DGHT-Kongress, Berlin, 20-21 September 2019.